Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Pediatric Cancer,2017,NIAMS,5R21AR066938-02,,Human artificial chromosome as vectors for gene therapy of a model skin disease,"MONACO, ZOIA",TUFTS UNIVERSITY MEDFORD,MA,"$208,548"
Pediatric Cancer,2017,NCI,5R01CA158768-06,,The Function of rpL5 and rpL11 in induction of p53,"THOMAS, GEORGE",FUNDACIO PRIVADA INT D'VEST BIOMEDICA,SPAIN,"$224,100"
Pediatric Cancer,2017,NCI,5R01CA181050-04,,KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN,"PULSIPHER, MICHAEL",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$90,772"
Pediatric Cancer,2017,NCI,5R21CA187412-03,,Impact of primary tumor development stage on prognosis and outcome in B-ALL,"CARLSON, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$100,931"
Pediatric Cancer,2017,NCI,5R01CA190980-03,,Contribution of development and age to breast cancer etiology,"BARCELLOS-HOFF, MARY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$501,556"
Pediatric Cancer,2017,NIEHS,5U13ES026496-02,,Childhood Leukemia International Consortium Scientific Annual Meetings,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$15,000"
Pediatric Cancer,2017,NINDS,7K08NS083626-03,,Elucidating Signaling Pathways for GABA-A Receptor Alpha5 in an Aggressive Subtype of Medulloblastomas,"SENGUPTA, SOMA",EMORY UNIVERSITY,GA,"$182,201"
Pediatric Cancer,2017,NINDS,1R01NS094218-01A1,,Focal Sustained Release Chemotherapy-Loaded Biomaterials at Tumor Sites,"KAPLAN, DAVID",TUFTS UNIVERSITY MEDFORD,MA,"$355,019"
Pediatric Cancer,2017,NCI,5R00CA178207-05,,Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma,"BENAVENTE ARIAS, CLAUDIA",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$236,243"
Pediatric Cancer,2017,NCI,5R01CA132640-16,,Role of heat shock factors (Hsfs) in tumorigenesis,"MIVECHI, NAHID",AUGUSTA UNIVERSITY,GA,"$270,000"
Pediatric Cancer,2017,NCI,5R01CA190964-03,,Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia,"VAN ETTEN, RICHARD",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$544,106"
Pediatric Cancer,2017,NCI,5R01CA191077-03,,Assay Development for NSD1 Methyltransferase Inhibitor Discovery,"KOLB, EDWARD",ALFRED I. DU PONT HOSP FOR CHILDREN,DE,"$312,244"
Pediatric Cancer,2017,NCI,5R21CA195356-02,,Role of ThPOK in HSC Maintenance and Leukemogenesis,"KAPPES, DIETMAR",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$199,013"
Pediatric Cancer,2017,NCI,5R21CA194829-03,,Metabolic regulation of T-ALL cellular proliferation and lifespan,"RATHMELL, JEFFREY",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$204,885"
Pediatric Cancer,2017,NCI,5R03CA201540-02,,Cognitive and Psychosocial Functioning of Children Treated for Retinoblastoma,"WILLARD, VICTORIA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$89,750"
Pediatric Cancer,2017,NCI,5R01CA190617-03,,Itraconazole Analogues to Treat Medulloblastoma,"HADDEN, MATTHEW",UNIVERSITY OF CONNECTICUT STORRS,CT,"$382,472"
Pediatric Cancer,2017,NCI,1R35CA197695-01A1,,Translating genomic discoveries to improved outcomes for high risk acute leukemia,"MULLIGHAN, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$1,071,276"
Pediatric Cancer,2017,NCI,5R01CA195519-02,,Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia,"FORMAN, STEPHEN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$272,213"
Pediatric Cancer,2017,NCI,5R01CA201184-02,,Biologic and Therapeutic Significance of miR-155 in AML,"MARCUCCI, GUIDO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$554,107"
Pediatric Cancer,2017,NCI,5R21CA202210-02,,Symptom progress and adverse health outcomes in adult childhood cancer survivors,"HUANG, I-CHAN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$195,206"
Pediatric Cancer,2017,NCI,5R01CA072669-20,,Cytotoxic-T-Lymphocyte (CTL) Therapy of AML,"BLAZAR, BRUCE",UNIVERSITY OF MINNESOTA,MN,"$294,076"
Pediatric Cancer,2017,NCI,5R03CA201953-02,,Adolescent tanning and social media,"MORENO, MEGAN",SEATTLE CHILDREN'S HOSPITAL,WA,"$46,473"
Pediatric Cancer,2017,NCI,5R01CA169784-04,,Genetic Dissection of Acute Myeloid Leukemia.,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$355,993"
Pediatric Cancer,2017,NCI,5R01CA172408-04,,Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies,"YANG, FENG-CHUN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$318,513"
Pediatric Cancer,2017,NCI,5R01CA174683-04,,Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia,"BHATIA, SMITA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$606,475"
Pediatric Cancer,2017,NCI,5R01CA182528-05,,Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$336,114"
Pediatric Cancer,2017,NCI,5R01CA178380-04,,Leukotriene-Induced Nestin Expression Promotes Medulloblastoma Tumorigenesis,"YANG, ZENG-JIE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$379,725"
Pediatric Cancer,2017,NCI,5R00CA181500-04,,The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development,"BLACKBURN, JESSICA",UNIVERSITY OF KENTUCKY,KY,"$248,999"
Pediatric Cancer,2017,NCI,5F31CA196330-02,,Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells,"ADANE, BINIAM",UNIVERSITY OF COLORADO DENVER,CO,"$29,728"
Pediatric Cancer,2017,NHLBI,5R01HL117976-04,,Epithelial mechanisms of inducible resistance to AML-associated pneumonia,"EVANS, SCOTT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$400,000"
Pediatric Cancer,2017,NCI,5R01CA167708-05,,Targeting AML with PI3K/AKT inhibitors and BH3-mimetics,"GRANT, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$284,794"
Pediatric Cancer,2017,NCI,5K07CA174728-04,,A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors,"DEVINE, KATIE",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$164,851"
Pediatric Cancer,2017,NCI,5R01CA194058-02,,Painted erythrocyte carriers for therapy of acute myeloid leukemia,"SIMBERG, DIMITRI",UNIVERSITY OF COLORADO DENVER,CO,"$352,151"
Pediatric Cancer,2017,NCI,5R21CA191818-02,,Proton minibeams: Overcoming proton beams inability to spare superficial tissues,"KRISHNAN, SUNIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,395"
Pediatric Cancer,2017,NCI,5R01CA185301-03,,Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention,"CALIGIURI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$352,275"
Pediatric Cancer,2017,NCI,5R01CA201230-02,,The role of H3K79 methylation in IDH-mutant leukemia,"BERNT, KATHRIN",UNIVERSITY OF COLORADO DENVER,CO,"$10,000"
Pediatric Cancer,2017,NCI,5R01CA090668-14,,FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia,"SMALL, DONALD",JOHNS HOPKINS UNIVERSITY,MD,"$291,600"
Pediatric Cancer,2017,NCI,5R21CA187548-02,,Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma,"BARANOWSKA-KORTYLEWICZ, JANINA",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$163,669"
Pediatric Cancer,2017,NCI,5R01CA118332-10,,Parent-Child Communication About Cancer,"COMPAS, BRUCE",VANDERBILT UNIVERSITY,TN,"$437,647"
Pediatric Cancer,2017,NCI,5R01CA142665-07,,Glucocorticoids in Lymphoblastic Leukemia,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$487,994"
Pediatric Cancer,2017,NIGMS,5R01GM117093-02,,Kinase-mediated assembly of the mRNA entry channel in 40S ribosomes,"KARBSTEIN, KATRIN",SCRIPPS FLORIDA,FL,"$416,481"
Pediatric Cancer,2017,NICHD,5R01HD086195-02,,Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors,"LI, YUANPEI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$325,775"
Pediatric Cancer,2017,NCI,5R01CA080728-17,,Dissection of eIF4E dependent mRNA export,"BORDEN, KATHERINE",UNIVERSITY OF MONTREAL,CANADA,"$210,799"
Pediatric Cancer,2017,NCI,5R21CA191989-02,,Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation,"DANHAUER, SUZANNE",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$168,563"
Pediatric Cancer,2017,NCI,5K08CA181340-04,,Targeting Chromatin Modifications in Leukemia with Trisomy 21,"LANE, ANDREW",DANA-FARBER CANCER INST,MA,"$155,991"
Pediatric Cancer,2017,NCI,5P30CA014236-43,5328,Neuro-Oncology Research Program,"KASTAN, MICHAEL",DUKE UNIVERSITY,NC,"$41,908"
Pediatric Cancer,2017,NHLBI,5R01HL130034-02,,The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML,"FRIEDMAN, ALAN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Pediatric Cancer,2017,NCI,5P01CA094237-15,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,519"
Pediatric Cancer,2017,NCI,5P01CA094237-15,7530,CHIMERIC T CELLS TARGETING NEUROBLASTOMA,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,506"
Pediatric Cancer,2017,NCI,5R43CA203351-02,,Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS,"MORGAN, LEE","DEKK-TEC, INC.",LA,"$90,362"
Pediatric Cancer,2017,NCI,5R01CA187219-02,,Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas,"POLLACK, IAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$356,618"
Pediatric Cancer,2017,NCI,5P30CA023108-38,5364,Protocol Review and Monitoring (PRMS),"LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$63,931"
Pediatric Cancer,2017,NCI,5P30CA008748-51,7572,Research Pharmacy,"MULLER, RAYMOND",SLOAN-KETTERING INST CAN RESEARCH,NY,"$239,419"
Pediatric Cancer,2017,NCI,5F30CA183507-04,,Cytotoxicity of MLN4924 in Acute Myeloid Leukemia,"KNORR, KATHERINE",MAYO CLINIC ROCHESTER,MN,"$23,878"
Pediatric Cancer,2017,NCI,5R01CA172398-05,,The role of ETV6 in T-cell acute lymphoblastic leukemia,"FERRANDO, ADOLFO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Pediatric Cancer,2017,NCI,5R21CA183623-03,,Pediatric Cancer Salvia Biorepository,"GRAHAM, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$245,885"
Pediatric Cancer,2017,NCI,5R01CA173636-05,,Role of TET2 mutations in malignant transformation and acute myeloid leukemia,"LEVINE, ROSS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$639,626"
Pediatric Cancer,2017,NCI,5F30CA183497-04,,Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia,"MCKENNEY, ANNA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$49,044"
Pediatric Cancer,2017,NCI,5R01CA172268-05,,The role of inhibitory receptors in leukemia development,"ZHANG, CHENGCHENG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$329,925"
Pediatric Cancer,2017,NCI,5R01CA201225-02,,Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy,"ARMISTEAD, PAUL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$500,397"
Pediatric Cancer,2017,NCI,2P30CA006516-52,5399,Program 4: Leukemia,"EBERT, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$43,922"
Pediatric Cancer,2017,NCI,2P30CA006516-52,5409,Program 30: Neuro-Oncology,"STILES, CHARLES",DANA-FARBER CANCER INST,MA,"$42,805"
Pediatric Cancer,2017,NCI,1R01CA211044-01,,Off-the-shelf engineered NK cells for the treatment of AML,"REZVANI, KATY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Pediatric Cancer,2017,NCI,5R01CA164024-05,,Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML,"HORTON, TERZAH",BAYLOR COLLEGE OF MEDICINE,TX,"$319,474"
Pediatric Cancer,2017,NCI,5R01CA172392-05,,Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion,"CASTELLINO, ROBERT",EMORY UNIVERSITY,GA,"$323,700"
Pediatric Cancer,2017,NCI,5F31CA192822-03,,Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia,"SMITH, RUSSELL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$23,996"
Pediatric Cancer,2017,NCI,2U24CA055727-23,,Childhood Cancer Survivor Study,"ARMSTRONG, GREGORY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$3,616,741"
Pediatric Cancer,2017,NINDS,5R01NS088219-03,,Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis,"GERSHON, TIMOTHY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$327,837"
Pediatric Cancer,2017,NIAID,5R01AI018757-35,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Pediatric Cancer,2017,NICHD,5R01HD079568-03,,MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS,"LUPO, JANINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$499,938"
Pediatric Cancer,2017,NCI,5P01CA084203-13,5337,Project 1: Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer,"MAYTIN, EDWARD",MASSACHUSETTS GENERAL HOSPITAL,MA,"$180,974"
Pediatric Cancer,2017,NINDS,5R01NS096236-02,,Targeting mechanisms of medulloblastoma formation,"VAN MEIR, ERWIN",EMORY UNIVERSITY,GA,"$386,460"
Pediatric Cancer,2017,NCI,1R01CA211614-01,,Targeting TET1 signaling to treat acute myeloid leukemia,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$430,865"
Pediatric Cancer,2017,NCI,1R01CA211328-01,,Regulation of the LIN28/let-7 pathway in cancer,"GREGORY, RICHARD",BOSTON CHILDREN'S HOSPITAL,MA,"$404,888"
Pediatric Cancer,2017,NHLBI,5R01HL117737-18,,Microchimerism as AlloImmunity,"NELSON, J.",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$477,844"
Pediatric Cancer,2017,NCI,1R01CA211963-01,,Ionizing radiation induced hematological malignancies,"ZHOU, DAOHONG",UNIV OF ARKANSAS FOR MED SCIS,AR,"$355,340"
Pediatric Cancer,2017,NCI,1R01CA211711-01,,APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY,"DRULEY, TODD",WASHINGTON UNIVERSITY,MO,"$388,615"
Pediatric Cancer,2017,NCI,5R01CA132685-10,,Molecular Mechanisms Regulating the Retinoblastoma Protein Family,"RUBIN, SETH",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$342,389"
Pediatric Cancer,2017,NINR,1R01NR016720-01,,PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care,"WOLFE, JOANNE",DANA-FARBER CANCER INST,MA,"$565,742"
Pediatric Cancer,2017,NCI,1R01CA212649-01,,Personalized vaccine for patients with AML,"AVIGAN, DAVID",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$739,429"
Pediatric Cancer,2017,NCI,1R01CA211996-01,,Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy,"CHOW, ERIC",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$742,626"
Pediatric Cancer,2017,NCI,1R01CA213131-01,,Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia,"KORTYLEWSKI, MARCIN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$428,441"
Pediatric Cancer,2017,NCI,1R01CA213138-01,,CD25-mediated feedback control of BCR-signaling and its oncogenic mimics,"MÜSCHEN, MARKUS",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$395,738"
Pediatric Cancer,2017,NCI,1R01CA204093-01A1,,A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma,"PANDIT-TASKAR, NEETA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$392,078"
Pediatric Cancer,2017,NINDS,5R01NS096368-02,,Regulation of Medulloblastoma Metastasis by Emp1,"WECHSLER-REYA, ROBERT",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$426,563"
Pediatric Cancer,2017,NIEHS,1R21ES027418-01,,Training Pediatric Health Care Providers as a Primary Information Source for Communicating Environmental Risks for Breast Cancer,"SILK, KAMI",MICHIGAN STATE UNIVERSITY,MI,"$228,277"
Pediatric Cancer,2017,NCI,5R01CA192924-03,,CSF2 receptor mediated actions in t(8;21) leukemia,"ZHANG, DONG-ER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$343,706"
Pediatric Cancer,2017,NCI,5R01CA142874-07,,Targeting PML for Leukemia Therapy,"PANDOLFI, PIER PAOLO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$465,791"
Pediatric Cancer,2017,NCI,5R01CA172040-05,,Microenvironment-Leukemia Communication Through Lectins,"HEISTERKAMP, NORA",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$336,150"
Pediatric Cancer,2017,NIDDK,5R01DK105014-03,,Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes,"HUANG, GANG",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$351,000"
Pediatric Cancer,2017,NINDS,1K08NS099427-01,,Targeting ATRX-Deficient Pediatric GBM,"KOSCHMANN, CARL",UNIVERSITY OF MICHIGAN,MI,"$163,263"
Pediatric Cancer,2017,NHLBI,1K08HL135434-01,,Targeting SETBP1 in Myeloproliferative Disorders,"STIEGLITZ, ELLIOT","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$179,928"
Pediatric Cancer,2017,NEI,1K08EY027464-01,,Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma,"DANIELS, ANTHONY",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$191,925"
Pediatric Cancer,2017,NCI,1K08CA212279-01,,Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma,"RALEIGH, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$177,124"
Pediatric Cancer,2017,NICHD,1R21HD090503-01,,Drug delivery system for enhancing radiation therapy in pediatric glioma,"SALTZMAN, W",YALE UNIVERSITY,CT,"$251,250"
Pediatric Cancer,2017,NCI,5R01CA084628-25,,"Telomerase in Development, Senescence and Neoplasia","DEPINHO, RONALD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$616,000"
Pediatric Cancer,2017,NCI,5R01CA157460-06,,Nonadherence: Undermining health outcomes in pediatric HSCT?,"PAI, AHNA",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$269,433"
Pediatric Cancer,2017,NCI,5R01CA174794-05,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$605,760"
Pediatric Cancer,2017,NCI,5F30CA186466-03,,Role of GSK3beta Subcellular Localization in AML Stemness,"IGNATZ-HOOVER, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$29,040"
Pediatric Cancer,2017,NCI,5R01CA166280-05,,Therapeutic Targeting of Leukemia-Microenvironmental Interactions,"CALVI, LAURA",UNIVERSITY OF ROCHESTER,NY,"$318,513"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6700,Cancer Prevention & Control,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$588,586"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6701,Developmental Biology and Solid Tumor,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$987,654"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6702,Hematalogical Malignancies,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$695,188"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6703,Neurobiology and Brain Tumors,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$325,816"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6704,Shared Resource Group1: Genomics and Statistics,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$188,781"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6707,Data and Safety Monitoring/NIH Policy,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$153,117"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6709,Early Phase Clinical Research Support,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$256,191"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6710,Senior Leadership,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$371,956"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6711,Planning and Evaluation,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$75,223"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6713,Administration,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$258,156"
Pediatric Cancer,2017,NCI,5P30CA021765-38,6716,Transdisciplinary Collaboration and Coordination,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$319,535"
Pediatric Cancer,2017,NCI,5R01CA194057-03,,Metabolic pathways in leukemia,"SCHUETZ, JOHN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$410,606"
Pediatric Cancer,2017,NCI,5R01CA195642-03,,Triad1 regulates myelopoiesis and functions as a leukemia suppressor,"EKLUND, ELIZABETH",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$353,419"
Pediatric Cancer,2017,NCI,5R01CA076167-14,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",AUGUSTA UNIVERSITY,GA,"$307,800"
Pediatric Cancer,2017,NCI,5R01CA183874-03,,Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma.,"JEDLICKA, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$355,706"
Pediatric Cancer,2017,NIBIB,5R01EB020613-02,,Rapid MRI acquisition for pediatric low-grade gliomas,"SETSOMPOP, KAWIN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$651,546"
Pediatric Cancer,2017,NIAID,5U01AI104342-05,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Pediatric Cancer,2017,NCI,1R15CA206051-01A1,,Developing Therapeutic Strategies for Histone H3.3 Mutant Tumors via Rational Targeting of Specific DNA Repair Pathways,"GUNJAN, AKASH",FLORIDA STATE UNIVERSITY,FL,"$429,583"
Pediatric Cancer,2017,NCI,1R03CA212800-01,,Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu,"HANKINSON, TODD",UNIVERSITY OF COLORADO DENVER,CO,"$77,750"
Pediatric Cancer,2017,NCI,5R01CA188520-03,,"Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy","BHASKARA, SRIVIDYA",UNIVERSITY OF UTAH,UT,"$340,838"
Pediatric Cancer,2017,NINDS,5R21NS096502-02,,Elucidating the drivers of medulloblastoma initiation and recurrence,"ROBBINS, DAVID",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$191,875"
Pediatric Cancer,2017,NCI,1R03CA212924-01,,Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment,"BENEDICT, CATHERINE",FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,NY,"$82,500"
Pediatric Cancer,2017,NCI,5P30CA014089-42,5249,Core-007,"GRUBER, STEPHEN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$498,596"
Pediatric Cancer,2017,NCI,5P30CA014089-42,5251,Core-009,"GRUBER, STEPHEN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$570,611"
Pediatric Cancer,2017,NCI,5R00CA181496-04,,Modeling p53 Mutant-Associated Cancer With LFS Patient-Derived iPSCs,"LEE, DUNG-FANG",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$243,144"
Pediatric Cancer,2017,NCI,1R01CA204044-01A1,,Regulation of TAL1/SCL in T-Cell Leukemia,"HUANG, SUMING",UNIVERSITY OF FLORIDA,FL,"$350,674"
Pediatric Cancer,2017,NCI,5R01CA166429-06,,Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia,"STEIDL, ULRICH","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$384,342"
Pediatric Cancer,2017,NCI,5R01CA170249-05,,PKA and follicular thyroid carcinogenesis: Roles of interacting pathways,"KIRSCHNER, LAWRENCE",OHIO STATE UNIVERSITY,OH,"$316,438"
Pediatric Cancer,2017,NIGMS,1R01GM118578-01A1,,Genetics-guided Individualization of Thiopurine Therapy,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$579,917"
Pediatric Cancer,2017,NCI,5R01CA193677-02,,Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma,"SCACHERI, PETER",CASE WESTERN RESERVE UNIVERSITY,OH,"$362,569"
Pediatric Cancer,2017,NCI,1R01CA204158-01A1,,Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC),"MAYTIN, EDWARD",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$490,760"
Pediatric Cancer,2017,NCI,5F31CA203053-02,,The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis,"SECHLER, MARYBETH",UNIVERSITY OF COLORADO DENVER,CO,"$13,205"
Pediatric Cancer,2017,NCI,5R01CA172387-05,,Polysomy 21 in Acute Lymphoblastic Leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$352,946"
Pediatric Cancer,2017,NCI,5R01CA174793-05,,BET bromodomain inhibition as targeted therapy in acute myeloid leukemia,"VAKOC, CHRISTOPHER",COLD SPRING HARBOR LABORATORY,NY,"$557,762"
Pediatric Cancer,2017,NCI,5R21CA194871-02,,Role of EMSY protein complexes in the FA DNA repair pathway,"SOBECK, ALEXANDRA",UNIVERSITY OF MINNESOTA,MN,"$162,828"
Pediatric Cancer,2017,NCI,1R01CA204258-01A1,,Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors,"NICHOLS, HAZEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$675,579"
Pediatric Cancer,2017,NCI,2R01CA154923-06A1,,Genetics of Rhabdomyosarcoma,"LANGENAU, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$406,125"
Pediatric Cancer,2017,NCI,1R01CA202261-01A1,,Improving HPV Vaccination Delivery in Pediatric Primary Care: The STOP-HPV Trial,"SZILAGYI, PETER",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$676,337"
Pediatric Cancer,2017,NCI,5R01CA180692-03,,Role of LMO1 in Neuroblastoma Initiation and Maintenance,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$606,838"
Pediatric Cancer,2017,NCI,5R01CA197336-02,,Transcriptional CDKs as therapeutic targets in MYC-dependent cancers,"GEORGE, RANI",DANA-FARBER CANCER INST,MA,"$407,748"
Pediatric Cancer,2017,NCI,5R01CA190843-03,,"A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia","SOHN, LYDIA",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$311,458"
Pediatric Cancer,2017,NCI,5K08CA194162-03,,The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas,"SCHNEPP, ROBERT",EMORY UNIVERSITY,GA,"$168,264"
Pediatric Cancer,2017,NCI,1R01CA204915-01A1,,Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics,"STEGMAIER, KIMBERLY",DANA-FARBER CANCER INST,MA,"$396,547"
Pediatric Cancer,2017,NCI,1R01CA204979-01A1,,Mechanisms of inv(16) acute myeloid leukemia,"CASTILLA, LUCIO",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$426,803"
Pediatric Cancer,2017,NCI,2R01CA158073-06A1,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$380,000"
Pediatric Cancer,2017,NCI,1R01CA204378-01A1,,Improving treatment of cardiovascular risk factors in childhood cancer survivors,"CHOW, ERIC",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$773,174"
Pediatric Cancer,2017,NCI,2R01CA159859-06,,Mouse models to discover new drivers of medulloblastoma,"WECHSLER-REYA, ROBERT",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$794,344"
Pediatric Cancer,2017,NCI,5R01CA193842-03,,Characterizing MSI2 in leukemia,"KHARAS, MICHAEL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$414,827"
Pediatric Cancer,2017,NCI,5R01CA187004-03,,Targeting MLL3 histone methyltransferase,"DOU, YALI",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Pediatric Cancer,2017,NCI,5R21CA205912-02,,Mediator Kinases and AML Cell Proliferation,"TAATJES, DYLAN",UNIVERSITY OF COLORADO,CO,"$172,855"
Pediatric Cancer,2017,NCI,5R01CA178454-05,,The role and functional mechanism of TET1 in MLL-rearranged leukemia,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$327,850"
Pediatric Cancer,2017,NCI,5R01CA163452-05,,Novel lysine deacetylase 6 Hsp domain inhibitors against AML,"CHOU, CHUNG-JEN JAMES",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$310,213"
Pediatric Cancer,2017,NCI,1K08CA201591-01A1,,Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells,"WANG, LEO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$169,560"
Pediatric Cancer,2017,NCI,5R01CA151898-07,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$392,969"
Pediatric Cancer,2017,NCI,5R01CA176091-05,,Crenolanib and ponatinib for the treatment of FLT3 mutant AML,"SHAH, NEIL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pediatric Cancer,2017,NCI,5R01CA201496-02,,Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia,"ROSEN, STEVEN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$463,530"
Pediatric Cancer,2017,NICHD,1R21HD087760-01A1,,Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndrome,"QU, CHENG-KUI",EMORY UNIVERSITY,GA,"$195,000"
Pediatric Cancer,2017,NCI,5R21CA195324-02,,Targeting insulin receptor splicing for treatment of rhabdomyosarcoma,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$164,349"
Pediatric Cancer,2017,NIMHD,5R01MD007801-04,,Reducing racial/ethnic inequities in childhood cancer survivorship,"MILAM, JOEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$412,142"
Pediatric Cancer,2017,NCI,5R01CA204308-02,,Modulating signaling pathways in endothelial cells to abate leukemic progression.,"BUTLER, JASON",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$383,445"
Pediatric Cancer,2017,NCI,5U01CA176063-04,,ARID5B and disparities of childhood leukemia,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$368,510"
Pediatric Cancer,2017,NCI,5R01CA193235-03,,Metabolic Regulation in Leukemia-Initatiating Cells,"NAKADA, DAISUKE",BAYLOR COLLEGE OF MEDICINE,TX,"$462,191"
Pediatric Cancer,2017,NCI,5R01CA177810-03,,Modulation of MicroRNAs with Xenobiotics to Target c-Myc,"LI, YONG",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$368,974"
Pediatric Cancer,2017,NCI,5R01CA197903-02,,Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma,"ZHONG, JOHN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$378,357"
Pediatric Cancer,2017,NCI,5R21CA197441-02,,Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$200,970"
Pediatric Cancer,2017,NCI,5F32CA206418-02,,Epigenetic Mechanisms of Oncohistone Detoxification,"DIEHL, KATHARINE",PRINCETON UNIVERSITY,NJ,"$56,694"
Pediatric Cancer,2017,NIGMS,5R01GM113100-03,,Gli1-selective inhibitors of the Hedgehog signaling pathway,"CHEN, JAMES",STANFORD UNIVERSITY,CA,"$350,738"
Pediatric Cancer,2017,NCI,5K99CA197498-03,,Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia,"CHEN, CHUN-WEI",DANA-FARBER CANCER INST,MA,"$154,058"
Pediatric Cancer,2017,NCI,5R01CA171338-05,,Novel Targeted Therapy for AML,"BHALLA, KAPIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Pediatric Cancer,2017,NCI,5R01CA181231-02,,A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling,"REITER, JEREMY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,569"
Pediatric Cancer,2017,NCI,5K99CA197484-02,,Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis,"HUANG, MILLER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$160,773"
Pediatric Cancer,2017,NINDS,5R01NS091219-03,,Targeting Wee1 in Myc driven Medulloblasoma,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$255,118"
Pediatric Cancer,2017,NCI,5R01CA166025-05,,Molecular Basis of Familial Paraganglioma,"MAHER, LOUIS",MAYO CLINIC ROCHESTER,MN,"$296,933"
Pediatric Cancer,2017,NCI,5UM1CA183730-04,,Collaborative Human Tissue Network (CHTN),"RAMIREZ, NILSA",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$774,914"
Pediatric Cancer,2017,NCI,5R01CA190661-02,,Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype,"STIREWALT, DEREK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$573,343"
Pediatric Cancer,2017,NCI,5U10CA180866-04,,Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.,"LEVINE, ELLIS",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$585,200"
Pediatric Cancer,2017,NCI,5R21CA205936-02,,SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia,"DEININGER, MICHAEL",UNIVERSITY OF UTAH,UT,"$164,620"
Pediatric Cancer,2017,NCI,5R01CA172067-06,,Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma,"DUBOIS, STEVEN",DANA-FARBER CANCER INST,MA,"$363,425"
Pediatric Cancer,2017,NCI,5R21CA205644-02,,(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy,"WHITESIDE, THERESA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$202,439"
Pediatric Cancer,2017,NCI,5R01CA206210-02,,Therapeutic targeting of glutamine metabolism in MDS,"KONOPLEVA, MARINA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$474,750"
Pediatric Cancer,2017,NCI,5UM1CA081457-19,,Pediatric Brain Tumor Consortium (PBTC),"ONAR-THOMAS, ARZU",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$2,728,300"
Pediatric Cancer,2017,NCI,5R01CA116548-12,,THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA,"METELITSA, LEONID",BAYLOR COLLEGE OF MEDICINE,TX,"$249,637"
Pediatric Cancer,2017,NCI,5R01CA196851-02,,Targeting vismodegib-resistant tumors using BH3 mimetics,"KIM, JAMES",UT SOUTHWESTERN MEDICAL CENTER,TX,"$346,985"
Pediatric Cancer,2017,NCI,5U10CA180899-04,,Children's Oncology Group Statistics and Data Center,"DEVIDAS, MEENAKSHI",UNIVERSITY OF FLORIDA,FL,"$7,008,867"
Pediatric Cancer,2017,NCI,5R03CA186910-02,,Parenting in the Face of Cancer: Non-Ill Sibling and Parent Relationships,"WALKER, AMY",UNIVERSITY OF WASHINGTON,WA,"$77,250"
Pediatric Cancer,2017,NCI,5R01CA173852-04,,Role of p21 activated kinase in Leukemogenesis,"KAPUR, REUBEN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Pediatric Cancer,2017,NCI,5R21CA190196-02,,Imaging Tumor Associated Macrophages in Bone Sarcomas,"DALDRUP-LINK, HEIKE",STANFORD UNIVERSITY,CA,"$206,204"
Pediatric Cancer,2017,NCI,5U24CA196173-03,,COG Biospecimen Bank,"RAMIREZ MILAN, NILSA",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$2,244,903"
Pediatric Cancer,2017,NCI,5R01CA192176-02,,Developmental studies to inform clinical stratification and targeting of SHH MB,"JOYNER, ALEXANDRA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$449,790"
Pediatric Cancer,2017,NCI,5R33CA191143-03,,Single cell growth assay for residual cells in acute lymphoblastic leukemia,"MANALIS, SCOTT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$450,496"
Pediatric Cancer,2017,NICHD,5R01HD081123-03,,Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT Scans,"DALDRUP-LINK, HEIKE",STANFORD UNIVERSITY,CA,"$492,552"
Pediatric Cancer,2017,NCI,5R01CA175231-05,,Reducing Skin Cancer Risk in Childhood Cancer Survivors,"GELLER, ALAN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$643,350"
Pediatric Cancer,2017,NCI,5P30CA013148-45,8603,04 Neuro-Oncology Program,"GILLESPIE, G.",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$108,080"
Pediatric Cancer,2017,NCI,5R01CA204586-02,,Yap and beta-catenin interactions in liver: Implications in Pathophysiology,"MONGA, SATDARSHAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$414,072"
Pediatric Cancer,2017,NCI,5K08CA204734-02,,Determining the Role of BCOR Mutations in Myeloid Malignancies,"LINDSLEY, ROBERT",DANA-FARBER CANCER INST,MA,"$176,970"
Pediatric Cancer,2017,NCI,1R41CA213690-01,,"AML-MutationCounter, a tool to detect residual and recurrent leukemia","KAUFMANN, WILLIAM","ASYSTBIO LABORATORIES, LLC",NC,"$220,087"
Pediatric Cancer,2017,NCI,1R44CA213595-01,,Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood,"MULLER, ROLF","BIOFLUIDICA, INC",NC,"$798,225"
Pediatric Cancer,2017,NINDS,5R01NS088355-03,,Targeting BET-bromodomains in neuroblastoma,"WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$675,172"
Pediatric Cancer,2017,NCI,5R01CA102031-12,,Pharmacological modulation of epigenetic changes in AML,"MARCUCCI, GUIDO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$342,107"
Pediatric Cancer,2017,NCI,5R01CA166749-06,,The Role of Growth Factor Receptor Trafficking in Tumorigenesis,"ZAGE, PETER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$315,213"
Pediatric Cancer,2017,NCI,5R01CA175216-02,,Testicular effects of modern chemotherapy regimens in osteosarcoma survivors,"SHNORHAVORIAN, MARGARETT",SEATTLE CHILDREN'S HOSPITAL,WA,"$644,375"
Pediatric Cancer,2017,NIDDK,5R01DK061470-14,,Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma,"CHUNG, DAI",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$409,278"
Pediatric Cancer,2017,NCI,1F30CA213878-01,,Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy,"GEORGE, JASON",RICE UNIVERSITY,TX,"$49,044"
Pediatric Cancer,2017,NCI,1F31CA213926-01,,Omics Approach to Interrogating Mechanism of ETV5 in Glioma,"PARK, HANNAH",CEDARS-SINAI MEDICAL CENTER,CA,"$37,644"
Pediatric Cancer,2017,NHLBI,1F31HL136107-01,,Function of the Ubiquitin-Specific Peptidase 22 (USP22) in Acute Myeloid Leukemia,"MELO-CARDENAS, JOHANNA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$38,255"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7522,Genomics of AML Clonality,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$328,402"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7523,Genomics of AML Relapse,"DIPERSIO, JOHN",WASHINGTON UNIVERSITY,MO,"$330,341"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7524,Genomics of Familial MDS/AML,"GRAUBERT, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$339,464"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7525,Genomics of Teatment-Related AML,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$334,581"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7526,Clinical Database,"WESTERVELT, PETER",WASHINGTON UNIVERSITY,MO,"$258,322"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7527,"Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling","PAYTON, JACQUELINE",WASHINGTON UNIVERSITY,MO,"$212,765"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7528,Sequencing and Integrated Analysis of AML Genomes,"WILSON, RICHARD",WASHINGTON UNIVERSITY,MO,"$986,260"
Pediatric Cancer,2017,NCI,5P01CA101937-14,7529,Administration,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$127,287"
Pediatric Cancer,2017,NCI,5R01CA129377-10,,Plasminogen activator inhibitor-1 in tumor progression and metastasis,"DECLERCK, YVES",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$239,246"
Pediatric Cancer,2017,NCI,5R01CA124709-10,,The Genetic Basis of Neuroblastoma Tumorigenesis,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$614,290"
Pediatric Cancer,2017,NCI,1U01CA202947-01A1,,Bench to bedside: non-invasive treatment of tumors in children,"KIM, PETER",CHILDREN'S RESEARCH INSTITUTE,DC,"$350,585"
Pediatric Cancer,2017,NCI,5R01CA176803-03,,Targeted- and timed-releasing nanotherapeutics against leukemia stem cells,"PAN, CHONG-XIAN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$359,138"
Pediatric Cancer,2017,NCI,5R01CA185062-04,,(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia,"FARRAR, MICHAEL",UNIVERSITY OF MINNESOTA,MN,"$312,304"
Pediatric Cancer,2017,NCI,5R01CA168622-05,,"Cell Fate Control by Integrated E2F, FoxO and PI3K Signaling in Retinoblastoma","HALLSTROM, TIMOTHY",UNIVERSITY OF MINNESOTA,MN,"$315,400"
Pediatric Cancer,2017,NCI,5R01CA193890-03,,HAUSP inhibitors in p53-wild type and p53-mutant tumors,"GU, WEI",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Pediatric Cancer,2017,NCI,5K99CA197640-02,,Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor,"WANG, XIAOFENG",DANA-FARBER CANCER INST,MA,"$151,649"
Pediatric Cancer,2017,NIAID,1R21AI129426-01,,Connecting Epigenetic Regulator MLL1 to ERK and Survival Signaling in B cells,"ERNST, PATRICIA",UNIVERSITY OF COLORADO DENVER,CO,"$228,355"
Pediatric Cancer,2017,NCI,5K07CA200668-02,,Patient Preferences and Adherence in Adolescents and Young Adults with Cancer,"MCGRADY, MEGHAN",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$144,855"
Pediatric Cancer,2017,NHLBI,5R01HL131444-02,,The role of EVI1-induced hypermethylation in leukemogenesis.,"QIAN, ZHIJIAN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$399,750"
Pediatric Cancer,2017,NCI,5R01CA175353-04,,Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu,"ROBINS, HARLAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$648,389"
Pediatric Cancer,2017,NCI,5R01CA174851-04,,A longitudinal assessment of frailty in young adult survivors of childhood cancer,"NESS, KIRSTEN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$538,152"
Pediatric Cancer,2017,NHLBI,5R01HL052725-23,,Molecular Pathogenesis of Fanconi Anemia,"D'ANDREA, ALAN",DANA-FARBER CANCER INST,MA,"$400,792"
Pediatric Cancer,2017,NCI,5K08CA174750-04,,Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy,"CAPITINI, CHRISTIAN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$178,740"
Pediatric Cancer,2017,NCI,5F30CA196244-03,,The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors,"SCOVILLE, STEVEN",OHIO STATE UNIVERSITY,OH,"$49,044"
Pediatric Cancer,2017,NCI,5R01CA142928-08,,Targeting the Kinome in Neurofibromatosis type 1,"CHERNOFF, JONATHAN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$434,625"
Pediatric Cancer,2017,NCI,5R01CA194923-03,,Long non-coding RNAs in hematopoiesis and blood malignancy,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$457,533"
Pediatric Cancer,2017,NCI,5U54CA193419-03,7381,Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer,"LICHT, JONATHAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$460,150"
Pediatric Cancer,2017,NCI,5R03CA205311-02,,Development of a mouse model of pediatric high-grade gliomas,"XIE, ZHIGANG",TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,"$74,250"
Pediatric Cancer,2017,NCI,5R01CA178030-04,,Regulation of transcription and tumor suppression by MTG family members,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$364,000"
Pediatric Cancer,2017,NCI,5R01CA185402-04,,(PQD-5) Patient derived orthotopic xenograft models for drug response prediction,"LI, XIONAN",BAYLOR COLLEGE OF MEDICINE,TX,"$318,923"
Pediatric Cancer,2017,NCI,5U54CA193461-03,7298,Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia,"SCADDEN, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$532,795"
Pediatric Cancer,2017,NIA,5R21AG052195-02,,Screening for enhancers of sAPPalpha,"JOHN, VARGHESE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$192,500"
Pediatric Cancer,2017,NCI,5K08CA184419-02,,Chemotherapy resistance induced by SETD2 loss in leukemia,"MAR, BRENTON",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2017,NCI,5R01CA190509-03,,The function of cyclin C in tumorigenesis,"SICINSKI, PETER",DANA-FARBER CANCER INST,MA,"$453,569"
Pediatric Cancer,2017,NHLBI,5R01HL115145-05,,Yes1 as a quiescence regulator in hematopoietic stem cells,"MUKHERJEE, SIDDHARTHA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$400,000"
Pediatric Cancer,2017,NCI,5R25CA023944-34,,PEDIATRIC ONCOLOGY EDUCATION (YEARS 33 - 37),"GRONEMEYER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$321,271"
Pediatric Cancer,2017,NCI,5K08CA181507-02,,Analysis of TET2 function in acute leukemia,"SHIH, ALAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,036"
Pediatric Cancer,2017,NCI,5K07CA166177-05,,Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation,"MOSTOUFI-MOAB, SOGOL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$164,862"
Pediatric Cancer,2017,NCI,5R01CA175761-04,,Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis,"PERKINS, ARCHIBALD",UNIVERSITY OF ROCHESTER,NY,"$318,513"
Pediatric Cancer,2017,NHLBI,5K08HL127269-03,,Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes,"GHIAUR, GABRIEL",JOHNS HOPKINS UNIVERSITY,MD,"$171,720"
Pediatric Cancer,2017,NCI,5R01CA193776-03,,Improving risk allocation and developing novel therapies for children with T-ALL,"TEACHEY, DAVID",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$625,779"
Pediatric Cancer,2017,NHLBI,5R01HL120724-03,,Balanced signaling cues to guide cell transitions in the blood lineage continuum,"ROOSE, JEROEN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$742,879"
Pediatric Cancer,2017,NCI,5R01CA194552-03,,RETARGETING AGENTS TO TREAT AML,"DIPERSIO, JOHN",WASHINGTON UNIVERSITY,MO,"$380,068"
Pediatric Cancer,2017,NCI,5R01CA197991-02,,Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia,"PARDEE, TIMOTHY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$354,563"
Pediatric Cancer,2017,NHLBI,5R01HL079571-13,,A Vital tool for the Study of DBA: The Diamond Blackfan Anemia Registry,"LIPTON, JEFFREY",FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,NY,"$420,957"
Pediatric Cancer,2017,NINR,5R01NR015458-03,,Building Evidence for Effective Palliative/End of Life Care for Teens with Cancer,"LYON, MAUREEN",CHILDREN'S RESEARCH INSTITUTE,DC,"$612,224"
Pediatric Cancer,2017,NCI,5R01CA173877-05,,Targeted Therapy for AML Stem Cells,"BHALLA, KAPIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Pediatric Cancer,2017,NCI,5R01CA133379-09,,The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$381,375"
Pediatric Cancer,2017,NCI,5R01CA132946-10,,Pharmacogenomics of Ara-C in AML,"LAMBA, JATINDER",UNIVERSITY OF FLORIDA,FL,"$310,602"
Pediatric Cancer,2017,NCI,5R01CA064140-24,,Role of AML1-ETO in Acute Leukemia,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$353,250"
Pediatric Cancer,2017,NHLBI,7R01HL126947-03,,Epigenetic biomarkers of response to Azacytidine in Myelodysplastic Syndromes,"FIGUEROA, MARIA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$390,375"
Pediatric Cancer,2017,NCI,5U10CA180886-04,,COG NCTN Network Group Operations Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$22,547,116"
Pediatric Cancer,2017,NCI,5R01CA188516-04,,Cooperating Pathways in Gliomagenesis,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$372,463"
Pediatric Cancer,2017,NCI,5U10CA180884-04,,COG NCTN Solid Malignancy Integrated Translational Science Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$400,000"
Pediatric Cancer,2017,NCI,5R01CA182284-05,,Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats,"COLE, PETER","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$346,525"
Pediatric Cancer,2017,NCI,5R01CA199111-33,,Opening of the Blood-Brain Barrier to Antitumor Agents,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$617,175"
Pediatric Cancer,2017,NINDS,5R01NS085336-04,,Pediatric low-grade gliomas: biology and molecular targeting.,"RESNICK, ADAM",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$367,500"
Pediatric Cancer,2017,NHLBI,5R01HL131744-02,,Molecular Genetics of Dyskeratosis Congenita,"BERTUCH, ALISON",BAYLOR COLLEGE OF MEDICINE,TX,"$512,031"
Pediatric Cancer,2017,NIGMS,5F31GM116569-02,,Developing an Artemis Nuclease Inhibitor to Potentially Treat Acute Lymphoblastic Leukemia,"ESGUERRA, ZITADEL ANNE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$42,686"
Pediatric Cancer,2017,NINDS,5R21NS095273-02,,Modulating the Nucleopathy caused by FUS Mutants of ALS,"HAYWARD, LAWRENCE",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$209,375"
Pediatric Cancer,2017,NCI,5R01CA140198-09,,Targeting Oncogenic ALK Signaling in Neuroblastoma,"MOSSE, YAEL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$374,324"
Pediatric Cancer,2017,NCI,5F31CA196265-03,,Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions,"DORAND, RODNEY",CASE WESTERN RESERVE UNIVERSITY,OH,"$49,044"
Pediatric Cancer,2017,NCI,7R21CA205309-02,,National trends in end of life care for adolescent and young adult cancer patients,"WERNLI, KAREN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$144,804"
Pediatric Cancer,2017,NICHD,5R01HD074587-05,,Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease,"PACZESNY, SOPHIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$491,398"
Pediatric Cancer,2017,NCI,5R01CA178765-05,,Transcriptional regulatory mechanisms in B cell development and leukemogenesis,"ROEDER, ROBERT",ROCKEFELLER UNIVERSITY,NY,"$565,455"
Pediatric Cancer,2017,NCI,1U01CA214116-01,,Proteogenomic Translational Research Center for Clinical Proteomic,"RODLAND, KARIN",BATTELLE PACIFIC NORTHWEST LABORATORIES,WA,"$1,374,609"
Pediatric Cancer,2017,NCI,5R25CA183725-03,,Problem-Solving Skills Training for Clinicians Providing Psychosocial Care in Pediatric Oncology,"SAHLER, OLLE JANE",UNIVERSITY OF ROCHESTER,NY,"$301,523"
Pediatric Cancer,2017,NINDS,5R01NS096954-02,,Novel K27M Mutation-derived Neoantigen for T Cell Therapy in Gliomas,"OKADA, HIDEHO","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$346,719"
Pediatric Cancer,2017,NIDDK,5R01DK103961-05,,Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes,"VERMA, AMIT","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$358,005"
Pediatric Cancer,2017,NCI,5R01CA098571-13,,Molecular Mechanisms of eIF4E mediated transformation,"BORDEN, KATHERINE",UNIVERSITY OF MONTREAL,CANADA,"$256,369"
Pediatric Cancer,2017,NCI,5F30CA192832-03,,ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development,"LANG, YUN LONG",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$34,282"
Pediatric Cancer,2017,NCI,5P30CA042014-28,5852,Clinical Protocol and Data Management,"AKERLEY, WALLACE",UNIVERSITY OF UTAH,UT,"$223,809"
Pediatric Cancer,2017,NCI,5R01CA090321-15,,Role of Sialic Acid Modification in ALL Survival and Drug Resistance,"HEISTERKAMP, NORA",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$266,069"
Pediatric Cancer,2017,NCI,5R00CA168996-05,,The role of Jmjd1c in normal and leukemic hematopoiesis,"ZHU, NAN","BLOODCENTER OF WISCONSIN, INC.",WI,"$238,701"
Pediatric Cancer,2017,NCI,5R01CA189806-04,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$541,564"
Pediatric Cancer,2017,NCI,5R01CA188269-04,,Developing CRM1 inhibitors in AML,"GARZON, RAMIRO",OHIO STATE UNIVERSITY,OH,"$319,550"
Pediatric Cancer,2017,NCI,5R01CA185058-04,,Impact of low IL-10 levels at birth and leukemia risk,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$606,390"
Pediatric Cancer,2017,NCI,5R01CA185039-04,,(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu,"JAN, LILY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$373,436"
Pediatric Cancer,2017,NCI,5R01CA183776-05,,"(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma","LESSNICK, STEPHEN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$309,175"
Pediatric Cancer,2017,NCI,5F31CA203161-02,,"Targeting PARP and RAD52 to induce ""dual synthetic lethality"" in leukemia patients identified by gene expression and mutation profiling","SULLIVAN, KATHERINE",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$29,663"
Pediatric Cancer,2017,NCI,5R01CA166327-05,,Regulation of Tumor Metabolism by Retinoblastoma Protein,"CLEM, BRIAN",UNIVERSITY OF LOUISVILLE,KY,"$311,250"
Pediatric Cancer,2017,NCI,5R01CA204585-02,,SCH: INT: Collaborative  Research Intelligent Information Sharing: Advancing Teamwork in Complex Care,"GROSZ, BARBARA",HARVARD UNIVERSITY,MA,"$402,248"
Pediatric Cancer,2017,NHLBI,5K08HL132101-02,,Early Clonal Evolution in Acquired Aplastic Anemia,"BABUSHOK, DARIA",UNIVERSITY OF PENNSYLVANIA,PA,"$169,776"
Pediatric Cancer,2017,NCI,5R01CA175759-05,,Creating and Validating Child Adverse Event Reporting in Oncology Trials,"REEVE, BRYCE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$616,962"
Pediatric Cancer,2017,NHLBI,5R01HL082945-11,,Functional Genomic Dissection of Refractory Anemia,"EBERT, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Pediatric Cancer,2017,NINDS,5R21NS094654-02,,TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA,"YANG, JIANHUA",BAYLOR COLLEGE OF MEDICINE,TX,"$237,750"
Pediatric Cancer,2017,NIGMS,1R35GM122546-01,,Mechanisms of Hedgehog Signal Transduction,"OGDEN, STACEY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$320,253"
Pediatric Cancer,2017,NCI,5P01CA096832-13,6145,Molecular Pathogenesis of Pediatric High Grade Glioma,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$472,412"
Pediatric Cancer,2017,NCI,5P01CA096832-13,6146,The DNA Damage Response and Tumorigenesis in the Brain,"MCKINNON, PETER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$430,294"
Pediatric Cancer,2017,NCI,5P01CA096832-13,6147,Collaborating Mutations in Medulloblastoma,"ROUSSEL (SHERR), MARTINE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$435,252"
Pediatric Cancer,2017,NCI,5P01CA096832-13,6148,Cellular and Molecular Origins of Medulloblastoma Subgroups,"GILBERTSON, RICHARD",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$436,114"
Pediatric Cancer,2017,NCI,5P01CA096832-13,8857,Core B,"BAKER, SUZANNE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$155,793"
Pediatric Cancer,2017,NCI,5R01CA163394-05,,Impact of chlorhexidine bathing on reducing infections in children with cancer,"ZERR, DANIELLE",SEATTLE CHILDREN'S HOSPITAL,WA,"$179,792"
Pediatric Cancer,2017,NCI,5R01CA172896-05,,Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells,"KIM, YONG-MI",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$335,154"
Pediatric Cancer,2017,NCI,5R01CA192652-03,,Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media,"BULLER, DAVID","KLEIN BUENDEL, INC.",CO,"$671,606"
Pediatric Cancer,2017,NCI,5R01CA173085-05,,Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia,"BRAUN, BENJAMIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Pediatric Cancer,2017,NCI,5U01CA202943-02,,Developing a translational pipeline for NF1-mutant malignancies,"CICHOWSKI, KAREN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$380,076"
Pediatric Cancer,2017,NCI,2P30CA006973-54,8081,Clinical Protocol and Data Management,"CARDUCCI, MICHAEL",JOHNS HOPKINS UNIVERSITY,MD,"$802,733"
Pediatric Cancer,2017,NCI,2P30CA006973-54,8084,Hematologic Malignancies and BMT Program - 02,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$55,302"
Pediatric Cancer,2017,NIGMS,2SC3GM102050-04,,Formulation of Fenretinide Nanoparticles for Enhanced Bioavailability,"BOSTANIAN, LEVON",XAVIER UNIVERSITY OF LOUISIANA,LA,"$105,768"
Pediatric Cancer,2017,NCI,1P01CA214278-01,8888,Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.,"PORTER, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$435,992"
Pediatric Cancer,2017,NCI,1P01CA214278-01,5000,Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells,"GILL, SAAR",UNIVERSITY OF PENNSYLVANIA,PA,"$266,231"
Pediatric Cancer,2017,NCI,2T32CA009351-39,,Pediatric Oncology Research Training Program,"BERNSTEIN, IRWIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$272,307"
Pediatric Cancer,2017,NCI,5U01CA184898-04,,Embryonal Brain Tumor Networks,"FRAENKEL, ERNEST",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$324,902"
Pediatric Cancer,2017,NCI,5R21CA205828-02,,Examining the role of normal hematopoiesis in supporting incipient myelodysplasia,"PERKINS, ARCHIBALD",UNIVERSITY OF ROCHESTER,NY,"$167,475"
Pediatric Cancer,2017,NCI,1R33CA214333-01,,Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer,"ZENG, YONG",UNIVERSITY OF KANSAS LAWRENCE,KS,"$400,098"
Pediatric Cancer,2017,NCI,5K08CA166229-05,,HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIA,"WARTMAN, LUKAS",WASHINGTON UNIVERSITY,MO,"$153,699"
Pediatric Cancer,2017,NCI,5K08CA188073-03,,Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma,"CROMPTON, BRIAN",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2017,NIDCR,5R01DE024392-04,,Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells,"VIGNESWARAN, NADARAJAH",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$383,932"
Pediatric Cancer,2017,NCI,5R01CA185687-03,,Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging,"SMITH-BINDMAN, REBECCA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$2,177,040"
Pediatric Cancer,2017,NCI,5P30CA013696-43,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Pediatric Cancer,2017,NCI,5P30CA013696-43,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$95,447"
Pediatric Cancer,2017,NCI,5R01CA193339-02,,Defective Myoblast Fusion Signaling in Rhabdomyosarcoma Pathogenesis,"GALINDO, RENE",UT SOUTHWESTERN MEDICAL CENTER,TX,"$370,575"
Pediatric Cancer,2017,NCI,5U24DA041123-03,,ABCD-USA Consortium: Data Analysis Center,"DALE, ANDERS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$750,000"
Pediatric Cancer,2017,NIDA,5U24DA041123-03,,ABCD-USA Consortium: Data Analysis Center,"DALE, ANDERS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$2,027,499"
Pediatric Cancer,2017,NCI,5K08CA191091-03,,Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia,"KNOECHEL, BIRGIT",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2017,NCI,5R01CA175215-05,,Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer,"RADICH, JERALD",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$579,042"
Pediatric Cancer,2017,NINDS,5R01NS097271-02,,Deconstruct tumor microenvironment in medulloblastoma,"ZONG, HUI",UNIVERSITY OF VIRGINIA,VA,"$429,572"
Pediatric Cancer,2017,NCI,1R01CA214965-01,,The role and mechanism of FTO in leukemogenesis and drug response,"CHEN, JIANJUN",UNIVERSITY OF CINCINNATI,OH,"$412,442"
Pediatric Cancer,2017,NCI,5R25CA102618-14,,Cancer Control Research Training Curriculum,"MORROW, GARY",UNIVERSITY OF ROCHESTER,NY,"$440,111"
Pediatric Cancer,2017,NCI,5R01CA196882-02,,Characterizing Histone Deacetylases in Rhabdomyosarcoma,"CHEN, ELEANOR",UNIVERSITY OF WASHINGTON,WA,"$318,077"
Pediatric Cancer,2017,NCI,5R01CA201069-02,,Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia,"OPFERMAN, JOSEPH",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$410,606"
Pediatric Cancer,2017,NCI,1R56CA215059-01,,The Role of DLST in Leukemogenesis,"FENG, HUI",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$376,294"
Pediatric Cancer,2017,NCI,5R01CA190261-03,,The impact of chromosome 17p lesions on leukemogeneis and therapy response,"LOWE, SCOTT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$402,371"
Pediatric Cancer,2017,NICHD,5R01HD083930-02,,Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation,"ZELINSKI, MARY",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$627,191"
Pediatric Cancer,2017,NCI,1R01CA215452-01,,Identifying and targeting oncogenic Myc enhancer control in pediatric tumors,"LIN, CHARLES",BAYLOR COLLEGE OF MEDICINE,TX,"$362,569"
Pediatric Cancer,2017,NHLBI,1R01HL136504-01,,TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS,"MAGEE, JEFFREY",WASHINGTON UNIVERSITY,MO,"$381,250"
Pediatric Cancer,2017,NCI,1R01CA215610-01,,ABT-199 based therapies to treat  neuroblastoma,"FABER, ANTHONY",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$371,856"
Pediatric Cancer,2017,NCI,1R01CA215489-01,,MYB family alterations in pediatric gliomas,"LIGON, KEITH",DANA-FARBER CANCER INST,MA,"$554,504"
Pediatric Cancer,2017,NCI,1R01CA215504-01,,Instructive role of MLL fusion proteins in lineage determination and leukemogenesis,"THIRMAN, MICHAEL",UNIVERSITY OF CHICAGO,IL,"$609,178"
Pediatric Cancer,2017,NCI,5F30CA206386-02,,Convection-enhanced Delivery of Radiosensitizer-Encapsulating Nanoparticles for the Treatment of Pediatric Brainstem Gliomas,"KING, AMANDA",YALE UNIVERSITY,CT,"$28,692"
Pediatric Cancer,2017,NCI,5K08CA190815-03,,REGULATORY MECHANISMS OF HOX GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA,"SPENCER, DAVID",WASHINGTON UNIVERSITY,MO,"$166,298"
Pediatric Cancer,2017,NCI,5R01CA187079-03,,Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission),"CONKLIN, HEATHER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$428,285"
Pediatric Cancer,2017,NICHD,5R01CA187079-03,,Prophylactic Multimodal Cognitive Intervention for Children with Medulloblastoma (Resubmission),"CONKLIN, HEATHER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$99,999"
Pediatric Cancer,2017,NCI,5R01CA057138-26,,Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways,"EISENMAN, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$635,460"
Pediatric Cancer,2017,NCI,5R21CA201809-02,,Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression,"FORD, HEIDE",UNIVERSITY OF COLORADO DENVER,CO,"$202,928"
Pediatric Cancer,2017,NCI,5U01CA199000-03,,Pediatric Preclinical Testing Consortium - Leukemia,"LOCK, RICHARD",UNIVERSITY OF NEW SOUTH WALES,AUSTRA,"$390,171"
Pediatric Cancer,2017,NCI,5R01CA163926-05,,Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia,"GREEN, MICHAEL",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$347,563"
Pediatric Cancer,2017,NCI,5R21CA198430-02,,Altered mitochondria-ER signaling as a cause of chemotherapy resistance,"HOGARTY, MICHAEL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$215,064"
Pediatric Cancer,2017,NCI,5R01CA036401-34,,Pharmacogenomics of Childhood Leukemia ALL,"EVANS, WILLIAM",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$726,540"
Pediatric Cancer,2017,NCI,5R01CA200574-02,,Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis,"ZHANG, LIANGFANG",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$359,138"
Pediatric Cancer,2017,NCI,5U01CA195547-03,,The St. Jude Lifetime Cohort,"HUDSON, MELISSA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$1,687,336"
Pediatric Cancer,2017,NCI,5R21CA201831-02,,SFK-inhibitor enhancement of ATRA-mediated differentiation of APL,"REDNER, ROBERT",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$169,106"
Pediatric Cancer,2017,NCI,5T32CA060441-25,,Lab Research Training in Pediatric Oncology-Hematology,"SMALL, DONALD",JOHNS HOPKINS UNIVERSITY,MD,"$583,961"
Pediatric Cancer,2017,NHLBI,1K08HL136894-01,,Hedgehog Signaling in the Progression of Myelodysplastic Syndromes,"GONDEK, LUKASZ",JOHNS HOPKINS UNIVERSITY,MD,"$171,720"
Pediatric Cancer,2017,NCI,5K08CA169485-05,,Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W,"CHAPUIS, AUDE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$171,372"
Pediatric Cancer,2017,NCI,5R01CA198089-03,,Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia,"CARROLL, MARTIN",UNIVERSITY OF PENNSYLVANIA,PA,"$663,135"
Pediatric Cancer,2017,NCI,5K08CA194256-03,,Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML),"GILL, SAAR",UNIVERSITY OF PENNSYLVANIA,PA,"$167,832"
Pediatric Cancer,2017,NCI,5R21CA201775-02,,Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL),"PARAMESWARAN, RESHMI",CASE WESTERN RESERVE UNIVERSITY,OH,"$172,369"
Pediatric Cancer,2017,NCI,5R01CA187318-03,,Molecular understanding of cytokine-Ras signals in leukemic bone marrow,"ROOSE, JEROEN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$353,777"
Pediatric Cancer,2017,NIGMS,5R01GM107490-04,,Sourcing Bioactive Secondary Metabolites from Great Lakes Fungi,"CICHEWICZ, ROBERT",UNIVERSITY OF OKLAHOMA NORMAN,OK,"$555,984"
Pediatric Cancer,2017,NINR,5R01NR015353-04,,Impact of a PCRC-Supported Legacy Intervention in Pediatric Palliative Care,"FOSTER, TERRAH",VANDERBILT UNIVERSITY,TN,"$442,863"
Pediatric Cancer,2017,NCI,5R01CA189074-03,,Small molecule CXCR4 modulators as molecular probes for studying AML,"SCHILTZ, GARY",NORTHWESTERN UNIVERSITY,IL,"$513,581"
Pediatric Cancer,2017,NCI,5R01CA195692-03,,Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management,"GUTMANN, DAVID",WASHINGTON UNIVERSITY,MO,"$551,530"
Pediatric Cancer,2017,NCI,5U01CA199287-03,,Pediatric Preclinical Testing Consortium,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$357,000"
Pediatric Cancer,2017,NCI,2K12CA090433-16,,Pediatric Oncology Clinical Research Training Program,"POPLACK, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$810,000"
Pediatric Cancer,2017,NCI,5R01CA104509-13,,Molecular Mechanism of Leukemogenesis Involving AML1-ETO,"ZHANG, DONG-ER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$331,313"
Pediatric Cancer,2017,NCI,5R35CA197561-03,,Molecular Pathogenesis of Acute Myeloid Leukemia,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$915,000"
Pediatric Cancer,2017,NCI,5R01CA174808-04,,Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells,"SHOHET, JASON",BAYLOR COLLEGE OF MEDICINE,TX,"$326,348"
Pediatric Cancer,2017,NCI,5R01CA193478-02,,Web-based Physical Activity Intervention for Children with ALL,"NESS, KIRSTEN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$869,905"
Pediatric Cancer,2017,NCI,5R01CA153354-06,,Study of Anti-Survival signals in NF1,"CHEN, CHANGYAN",NORTHEASTERN UNIVERSITY,MA,"$225,443"
Pediatric Cancer,2017,NCI,5F30CA186633-04,,Defining novel drivers and predictive signatures of metastasis in osteosarcoma th,"MORROW, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$49,044"
Pediatric Cancer,2017,NIDDK,1R01DK113639-01,,Targeting IRAK1/4 in Myelodysplastic Syndromes,"STARCZYNOWSKI, DANIEL",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$491,203"
Pediatric Cancer,2017,NCI,1R21CA215867-01,,PQ6: Role of Cellular Senescence in Late Effects of Childhood Cancer Therapy,"BRAM, RICHARD",MAYO CLINIC ROCHESTER,MN,"$207,495"
Pediatric Cancer,2017,NCI,5R01CA199937-03,,Image-guided doxorubicin delivery for pediatric sarcomas,"CHOPRA, RAJIV",UT SOUTHWESTERN MEDICAL CENTER,TX,"$579,143"
Pediatric Cancer,2017,NCI,5R01CA209829-02,,Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia,"PAYNE, KIMBERLY",LOMA LINDA UNIVERSITY,CA,"$360,547"
Pediatric Cancer,2017,NCI,1R21CA205106-01A1,,A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies,"OGEMBO, JAVIER",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$234,992"
Pediatric Cancer,2017,NCI,5F30CA203292-02,,"Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies","SWAROOP, ALOK",UNIVERSITY OF FLORIDA,FL,"$38,371"
Pediatric Cancer,2017,NCI,5R01CA197964-03,,Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor,"KITLINSKA, JOANNA",GEORGETOWN UNIVERSITY,DC,"$348,597"
Pediatric Cancer,2017,NCI,5R21CA202488-02,,Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia,"SWORDS, RONAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$166,931"
Pediatric Cancer,2017,NCI,5R01CA196703-03,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",BOSTON CHILDREN'S HOSPITAL,MA,"$404,888"
Pediatric Cancer,2017,NCI,5K01CA186943-03,,Childhood Infection and Pubertal Timing,"MCDONALD, JASMINE",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$139,358"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7544,CPML - Core A: Administrative Core,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$204,478"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7545,CPML - Core B: Cell & Molecular Core,"CREWS, KRISTINE",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$348,034"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7546,CPML - Core C: Bioinformatics & Biostatistical Core,"ZHANG, JINGHUI",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$596,871"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7547,CPML - Project 1: Genome-wide Studies of ALL Response,"MULLIGHAN, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$737,381"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7548,CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity,"EVANS, WILLIAM",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$707,707"
Pediatric Cancer,2017,NIGMS,5P50GM115279-03,7549,CPML - Project 3: Genome-wide Studies of Adverse Effects,"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$369,780"
Pediatric Cancer,2017,NINDS,5R01NS089868-04,,"MYCN, mTOR and translation control in medulloblastoma","WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$603,492"
Pediatric Cancer,2017,NINDS,5R01NS088283-04,,Role of EZH2 in Medulloblastoma Tumorigenesis,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$340,156"
Pediatric Cancer,2017,NCI,1R21CA215968-01,,Investigating developmental Hox programs as determinants of sarcomagenesis,"LAWLOR, ELIZABETH",UNIVERSITY OF MICHIGAN,MI,"$202,275"
Pediatric Cancer,2017,NCI,1R03CA215940-01,,Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma,"YUSTEIN, JASON",BAYLOR COLLEGE OF MEDICINE,TX,"$75,288"
Pediatric Cancer,2017,NCI,5P30CA125123-11,8013,Cancer Cell and Gene Therapy Program (Project-005),"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$43,684"
Pediatric Cancer,2017,NCI,5P30CA125123-11,8015,Pediatric Cancer Program (Project-007),"POPLACK, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$43,684"
Pediatric Cancer,2017,NHLBI,2R01HL076712-10,,Role of FA Proteins in Hematopoiesis,"PANG, QISHEN",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$397,500"
Pediatric Cancer,2017,NCI,5F30CA196095-02,,The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis,"MCAULEY, JAMES",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$49,044"
Pediatric Cancer,2017,NCI,5R21CA202296-02,,HSC-Independent Mechanisms Underlying JMML,"KAPUR, REUBEN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$205,538"
Pediatric Cancer,2017,NCI,1R01CA216421-01,,The cohesin complex as a tumor suppressor in myeloid leukemia,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$536,993"
Pediatric Cancer,2017,NCI,1R01CA207086-01A1,,Mechanisms of KLF4 suppression in pediatric leukemia,"LACORAZZA, DANIEL",BAYLOR COLLEGE OF MEDICINE,TX,"$326,540"
Pediatric Cancer,2017,NCI,1R01CA216344-01,,Defining the non-myogenic origins of pediatric rhabdomyosarcoma,"HATLEY, MARK",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$410,606"
Pediatric Cancer,2017,NCI,1R01CA216352-01,,In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$338,672"
Pediatric Cancer,2017,NCI,1R01CA216354-01,,Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing,"YASUI, YUTAKA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$732,780"
Pediatric Cancer,2017,NCI,5F31CA210408-02,,Modeling pediatric gliomas using a human pluripotent stem cell-based platform,"SMITH, RYAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$28,044"
Pediatric Cancer,2017,NCI,5K08CA193915-03,,The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome,"KALISH, JENNIFER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$140,504"
Pediatric Cancer,2017,NCI,5R03CA186176-02,,Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention,"LIU, SHUJUN",UNIVERSITY OF MINNESOTA,MN,"$77,500"
Pediatric Cancer,2017,NHLBI,5R33HL123655-04,,hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin Cardiotoxicity,"BERNSTEIN, DANIEL",STANFORD UNIVERSITY,CA,"$474,934"
Pediatric Cancer,2017,NINDS,5R01NS093079-03,,Targeting histone demethylase activity for the treatment of pediatric brainstem glioma,"HASHIZUME, RINTARO",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$309,000"
Pediatric Cancer,2017,NCI,5K12CA076930-17,,Career Development in Pediatric and Medical Oncology,"BERNSTEIN, IRWIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$701,719"
Pediatric Cancer,2017,NCI,5T32CA099936-13,,Translational Pediatric Cancer Epidemiology Research Training Grant,"SPECTOR, LOGAN",UNIVERSITY OF MINNESOTA,MN,"$202,592"
Pediatric Cancer,2017,NCI,1R01CA204297-01A1,,The epigenetic mechanisms of high-grade pediatric glioblastoma,"ZHANG, ZHIGUO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$380,348"
Pediatric Cancer,2017,NCI,5U01CA199288-03,,In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models,"LI, XIONAN",BAYLOR COLLEGE OF MEDICINE,TX,"$578,693"
Pediatric Cancer,2017,NCI,5R01CA172443-04,,Targeting NEDD8-Mediated Protein Turnover in AML,"CAREW, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$286,661"
Pediatric Cancer,2017,NCI,5R21CA202390-02,,PRMT1-mediated metabolic reprogramming in leukemia progression,"ZHAO, XINYANG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$191,835"
Pediatric Cancer,2017,NINDS,5K08NS097624-02,,Investigation of Histone H3 Post-Translational Modifications in Pediatric Brainstem Glioma,"SARATSIS, AMANDA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$186,398"
Pediatric Cancer,2017,NINR,5R01NR015789-02,,Mechanisms of Active Music Engagement to Improve Health Outcomes of Children with Cancer and Parents,"ROBB, SHERI",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$455,932"
Pediatric Cancer,2017,NHLBI,1R01HL132921-01A1,,Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis,"NALEPA, GRZEGORZ",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$393,750"
Pediatric Cancer,2017,NCI,2R01CA101774-15,,Mechanisms of Leukemogenesis in Down Syndrome,"CRISPINO, JOHN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$336,656"
Pediatric Cancer,2017,NCI,2R01CA148688-06A1,,The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma,"GEORGE, RANI",DANA-FARBER CANCER INST,MA,"$413,844"
Pediatric Cancer,2017,NCI,1R01CA210911-01A1,,Targeting the TGIF/Twist1 network in osteosarcoma,"ATFI, AZEDDINE",UNIVERSITY OF MISSISSIPPI MED CTR,MS,"$348,844"
Pediatric Cancer,2017,NCI,1R01CA201235-01A1,,Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia,"ENGEL, MICHAEL",UNIVERSITY OF UTAH,UT,"$346,271"
Pediatric Cancer,2017,NCI,1R01CA172513-01A1,,Role of PTEN and PI-3 kinase in medulloblastomagenesis,"DURDEN, DONALD",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$315,619"
Pediatric Cancer,2017,NCI,1R01CA207983-01A1,,Exosomes in tumor cell-mesenchymal stromal cell interaction,"DECLERCK, YVES",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$423,016"
Pediatric Cancer,2017,NCI,5R01CA163870-05,,Comb External Beam Radiotherapy with 153Sm-EDTMP to Treat High Risk Osteosarcoma,"LOEB, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$306,406"
Pediatric Cancer,2017,NCI,5F30CA210588-02,,EWS/FLI Regulates Transcriptional Activation in Ewing Sarcoma via Length Dependent GGAA Microsatellites,"JOHNSON, KIRSTEN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$49,044"
Pediatric Cancer,2017,NCI,5R01CA096899-12,,Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis,"KELLIHER, MICHELLE",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$358,031"
Pediatric Cancer,2017,NCI,5F31CA206322-02,,Mechanism of the methyltransferase Prdm3 in MLL leukemogenesis,"MCGLYNN, KELLY",UNIVERSITY OF ROCHESTER,NY,"$44,044"
Pediatric Cancer,2017,NCI,5K07CA196985-03,,Translational Approaches to Melanoma Prevention in Children at High Genetic Risk,"WU, YELENA",UNIVERSITY OF UTAH,UT,"$136,555"
Pediatric Cancer,2017,NICHD,1R03HD089190-01A1,,Examining Signals That Sculpt Cranial Neural Crest Migration,"KULESA, PAUL",STOWERS INSTITUTE FOR MEDICAL RESEARCH,MO,"$82,500"
Pediatric Cancer,2017,NCI,1R03CA216466-01,,Modeling Mdm2- and 12q amplicon-driven sarcoma,"MANFREDI, JAMES",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$83,493"
Pediatric Cancer,2017,NCI,5F31CA210607-02,,Discovery of pathogenic germline variants in pediatric cancers using genomics.,"MADUBATA, CHIOMA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$40,106"
Pediatric Cancer,2017,NCI,5R21CA209229-02,,Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia,"SCHJERVEN, HILDE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$184,753"
Pediatric Cancer,2017,NCI,5F31CA196045-03,,The role of PRDM16 in Leukemia,"CORRIGAN, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$41,070"
Pediatric Cancer,2017,NCI,5R01CA190957-03,,MYC-dependent loss of splicing fidelity in Glioblastoma multiforme,"PADDISON, PATRICK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$439,976"
Pediatric Cancer,2017,NCI,1K08CA201611-01A1,,DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA,"RAU, RACHEL",BAYLOR COLLEGE OF MEDICINE,TX,"$162,148"
Pediatric Cancer,2017,NCI,5R01CA169368-05,,Therapeutic Exploitation of Mutant BRAF for Astrocytoma,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$494,568"
Pediatric Cancer,2017,NCI,5R01CA196658-02,,A rapid spontaneous murine model of CN-AML,"GRIMES, H.",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$575,500"
Pediatric Cancer,2017,NCI,1K99CA207731-01A1,,Discovery of Synthetic Lethal Targets for Recurrent Epigenetic Mutations in Acute Myeloid Leukemia,"THOMAS, DANIEL",STANFORD UNIVERSITY,CA,"$173,448"
Pediatric Cancer,2017,NCI,1K08CA201640-01A1,,Developing differentiation therapy for the treatment of patients with acute myeloid leukemia,"SYKES, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$169,268"
Pediatric Cancer,2017,NCI,5F30CA210334-02,,Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG),"SCHUELKE, MATTHEW",MAYO CLINIC ROCHESTER,MN,"$44,244"
Pediatric Cancer,2017,NCI,5R01CA187903-03,,CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA,"RUAL, JEAN-FRANCOIS",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Pediatric Cancer,2017,NCI,5F31CA203252-02,,Determining the Role of Tumor-Associated Macrophages in oHSV Antitumor Efficacy in Ewing Sarcoma and Rhabdomyosarcoma,"DENTON, NICHOLAS",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$35,132"
Pediatric Cancer,2017,NCI,5R01CA204974-02,,Structural Variation in Neuroblastoma,"DISKIN, SHARON",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$384,300"
Pediatric Cancer,2017,NCI,5R35CA197078-03,,Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome,"SONDEL, PAUL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$917,202"
Pediatric Cancer,2017,NCI,5U01CA199297-03,,Pediatric Preclinical Testing Consortium: Research Programs Non-CNS (U01),"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$610,422"
Pediatric Cancer,2017,NIDDK,5R01DK107286-02,,Signaling Pathways in MDS,"SAKAMOTO, KATHLEEN",STANFORD UNIVERSITY,CA,"$350,691"
Pediatric Cancer,2017,NCI,5T32CA009659-22,,Training Physician Scientists in Pediatric Oncology,"DECLERCK, YVES",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$136,153"
Pediatric Cancer,2017,NCI,5U01CA199222-03,,Pediatric Preclinical Testing Consortium: Coordinating Center,"ROWSHAN, SUDIE",RESEARCH TRIANGLE INSTITUTE,NC,"$467,618"
Pediatric Cancer,2017,NCI,7R01CA201444-02,,Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment,"MITTELMAN, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$396,181"
Pediatric Cancer,2017,NCI,5R21CA198042-02,,Follow-up care and preventive service use among survivors of adolescent and young adult cancer.,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$177,068"
Pediatric Cancer,2017,NCI,5R01CA195563-03,,Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas,"MITCHELL, DUANE",UNIVERSITY OF FLORIDA,FL,"$633,869"
Pediatric Cancer,2017,NIDCD,5K23DC014291-02,,Prevention of Cisplatin-induced Hearing Loss in Children with Cancer,"ORGEL, ETAN",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$193,191"
Pediatric Cancer,2017,NCI,1R21CA216551-01,,Targeting DNA Base Excision Repair in Acute Myeloid Leukemias,"LLOYD, R.",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$200,970"
Pediatric Cancer,2017,NCI,1R03CA208021-01A1,,Estimating and communicating spatial certainty when childhood cancers co-cluster,"THOMPSON, JAMES",TEXAS A&M UNIVERSITY,TX,"$74,250"
Pediatric Cancer,2017,NCI,5F30CA200227-02,,Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?,"CERABONA, DONNA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$49,044"
Pediatric Cancer,2017,NCI,5R01CA196604-03,,Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia,"CHIANG, MARK",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Pediatric Cancer,2017,NCI,5R01CA187397-04,,Exercise and QUality diet After Leukemia,"TONOREZOS, EMILY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$621,296"
Pediatric Cancer,2017,NCI,5R01CA208405-02,,Modeling pediatric glioma in human ES cells:mechanistic and therapeutic insights,"TABAR, VIVIANE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$392,390"
Pediatric Cancer,2017,NCI,1R01CA204231-01A1,,Cohesin Mutations in Acute Myelogenous Leukemia,"RAO, SRIDHAR","BLOODCENTER OF WISCONSIN, INC.",WI,"$391,588"
Pediatric Cancer,2017,NCI,5R01CA175026-04,,Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML,"REDELL, MICHELE",BAYLOR COLLEGE OF MEDICINE,TX,"$379,294"
Pediatric Cancer,2017,NIGMS,1R01GM123554-01A1,,Role of DNA Replication Stress in Genome Instability and Cancer,"CAMPBELL, JUDITH",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$330,739"
Pediatric Cancer,2017,NCI,5R01CA175737-04,,Perinatal immune development and risk of childhood acute lymphoblastic leukemia,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$675,204"
Pediatric Cancer,2017,NCI,5K08CA201638-02,,Elucidating and exploiting the mechanisms by which IL-6 and IL-8 facilitate osteosarcoma metastasis,"ROBERTS, RYAN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$163,080"
Pediatric Cancer,2017,NCI,1R21CA208937-01A1,,Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML,"RASSOOL, FEYRUZ",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$201,459"
Pediatric Cancer,2017,NCI,5R01CA196854-03,,Reducing risk of Anthracycline-related heart failure after childhood cancer,"ARMENIAN, SARO",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$610,389"
Pediatric Cancer,2017,NCI,5R01CA189299-03,,Cytokine- and Satellite Cell-mediated Muscle Disease Promotion,"KELLER, CHARLES",CHILDREN'S CANCER THERAPY DEVELOP/INST,OR,"$337,941"
Pediatric Cancer,2017,NCI,5R00CA188293-04,,Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL,"NTZIACHRISTOS, PANAGIOTIS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$249,000"
Pediatric Cancer,2017,NCI,5K08CA177927-05,,Exploring Sarcoma Metastatic Potential,"WEISS, KURT",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$165,456"
Pediatric Cancer,2017,NIDDK,5F30DK108532-02,,microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.,"WEISS, CARY","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$49,044"
Pediatric Cancer,2017,NCI,5F31CA206338-02,,Myc transcriptional regulation in T-ALL,"FORSYTH, KATHERINE",UNIVERSITY OF PENNSYLVANIA,PA,"$44,044"
Pediatric Cancer,2017,NCI,5K22CA201103-02,,Targeting nutrient-sensing pathways in cancer,"LAZARUS, MICHAEL",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$191,360"
Pediatric Cancer,2017,NCI,5U01CA183030-04,,Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML,"LIU, YANG",CHILDREN'S RESEARCH INSTITUTE,DC,"$521,464"
Pediatric Cancer,2017,NCI,5UG1CA189862-04,,Puerto Rico NCI Community Oncology Research Program Minority/Underserved,"BAEZ, LUIS",COMPREHENSIVE CANCER CENTER/ UNIV/PR,PR,"$902,609"
Pediatric Cancer,2017,NIEHS,5U01ES026122-03,,Pregnancy and Prenatal PAHs and other Environmental Exposures and Breast Cancer,"TERRY, MARY BETH",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$898,251"
Pediatric Cancer,2017,NCI,5R01CA168452-05,,Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6,"CHOU, MARGARET",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$259,058"
Pediatric Cancer,2017,NINDS,5R01NS086956-04,,Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma,"VIBHAKAR, RAJEEV",UNIVERSITY OF COLORADO DENVER,CO,"$346,576"
Pediatric Cancer,2017,NCI,5R21CA202485-02,,A novel oncogenic driver in Ewing sarcoma,"SHIIO, YUZURU",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$165,844"
Pediatric Cancer,2017,NICHD,1R21HD091877-01,,Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial,"CHUBAK, JESSICA",KAISER FOUNDATION HEALTH PLAN OF WASHINGTON,WA,"$23,568"
Pediatric Cancer,2017,RMAP,5K01ES026842-03,,Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia,"PAGUIRIGAN, AMY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$119,735"
Pediatric Cancer,2017,NCI,5P30CA196521-03,7057,Clinical Protocol and Data Management/Clinical Trials Office (Core-007),"POSNER, MARSHALL",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$164,991"
Pediatric Cancer,2017,NCI,5K07CA178100-05,,A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors,"HOCKING, MATTHEW",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$129,957"
Pediatric Cancer,2017,NIGMS,5P30GM106396-05,8530,Animal Model Core,"CHESNEY, JASON",UNIVERSITY OF LOUISVILLE,KY,"$235,461"
Pediatric Cancer,2017,NCI,5R42CA168107-04,,Using game mechanics to improve outcomes among stem cell transplant survivors,"MCLAUGHLIN, JEFFERY","RADIANT CREATIVE GROUP, LLC",TX,"$307,237"
Pediatric Cancer,2017,NCI,5R01CA176624-04,,Tsc1/mTOR axis in immune homeostasis and tumorigenesis,"CHI, HONGBO",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$372,463"
Pediatric Cancer,2017,NCI,5UG1CA189973-04,,The Florida Pediatric NCORP,"SALMAN, EMAD",FLORIDA ASSN OF PEDIATRIC TUMOR PROG,FL,"$635,000"
Pediatric Cancer,2017,NCI,5K99CA201592-02,,Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma,"BANDOPADHAYAY, PRATITI",DANA-FARBER CANCER INST,MA,"$151,039"
Pediatric Cancer,2017,NHLBI,5R01HL128173-03,,Multiscale Modeling of Myelodysplastic Syndromes,"COREY, SETH",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$729,676"
Pediatric Cancer,2017,NCI,5UG1CA189955-04,,COG NCORP Research Base,"POLLOCK, BRAD",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$3,690,706"
Pediatric Cancer,2017,NCI,5UG1CA189958-04,,Nemours NCI Community Oncology Research Program (NCORP),"SANDLER, ERIC",ALFRED I. DU PONT HOSP FOR CHILDREN,DE,"$388,215"
Pediatric Cancer,2017,NCI,5R01CA193651-03,,Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL,"GUTIERREZ, ALEJANDRO",BOSTON CHILDREN'S HOSPITAL,MA,"$446,954"
Pediatric Cancer,2017,NCI,5F31CA206463-02,,Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia,"CONTRERAS-TRUJILLO, HUMBERTO",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$43,477"
Pediatric Cancer,2017,NCI,5P30CA047904-29,6381,Clinical Protocol and Data Management/Clinical Trials Office (Core 016),"BRUFSKY, ADAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$529,651"
Pediatric Cancer,2017,NCI,5R00CA184411-05,,Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3,"LI, LING",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$248,999"
Pediatric Cancer,2017,NCI,5K01CA188151-03,,Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML,"OROZCO, JOHNNIE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$169,020"
Pediatric Cancer,2017,NCI,5R00CA181488-04,,The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia,"LOSMAN, JULIE",DANA-FARBER CANCER INST,MA,"$249,000"
Pediatric Cancer,2017,NCI,5K08CA187577-04,,Investigating Resistance to FLT3 Inhibitors in AML,"SMITH, CATHERINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$175,808"
Pediatric Cancer,2017,NCI,5UG1CA189817-04,,Bay Area Tumor Institute NCORP,"BAILEY, LISA",BAY AREA TUMOR INSTITUTE,CA,"$690,000"
Pediatric Cancer,2017,NCI,5K08CA193982-03,,The Interaction of Autophagy and BRAF Mutations in Brain Tumors,"MULCAHY LEVY, JEAN",UNIVERSITY OF COLORADO DENVER,CO,"$164,393"
Pediatric Cancer,2017,NCI,5F30CA210518-02,,Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML,"DENG, LISA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$36,469"
Pediatric Cancer,2017,NCI,5P50CA100632-15,,SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia,"KANTARJIAN, HAGOP",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$2,300,000"
Pediatric Cancer,2017,NCI,5UG1CA189855-04,,South Texas Pediatric NCI Community Oncology Research Program (NCORP),"LANGEVIN, ANNE-MARIE",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$706,771"
Pediatric Cancer,2017,NHLBI,5R01HL130995-02,,Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment,"QU, CHENG-KUI",EMORY UNIVERSITY,GA,"$390,000"
Pediatric Cancer,2017,NINDS,5U01NS082328-04,,Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma,"ABOODY, KAREN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$949,003"
Pediatric Cancer,2017,NCI,1F30CA217006-01,,Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia,"FATEHCHAND, KAVIN",OHIO STATE UNIVERSITY,OH,"$39,139"
Pediatric Cancer,2017,NCI,2U01HG006485-05,,Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$900,000"
Pediatric Cancer,2017,NHGRI,2U01HG006485-05,,Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: The KidsCanSeq Study,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$1,901,395"
Pediatric Cancer,2017,NCI,5P30CA093373-15,8697,Clinical Protocol and Data Management,"KELLY, KAREN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$292,034"
Pediatric Cancer,2017,NCI,5K08CA188529-04,,Genomic profiling and development of murine models of transformation of MPNs,"RAMPAL, RAAJIT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$178,200"
Pediatric Cancer,2017,NCI,5R01CA188314-03,,Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor,"GROHAR, PATRICK",VAN ANDEL RESEARCH INSTITUTE,MI,"$391,163"
Pediatric Cancer,2017,NCI,5R35CA210030-02,,Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer,"STEGMAIER, KIMBERLY",DANA-FARBER CANCER INST,MA,"$1,046,441"
Pediatric Cancer,2017,NCI,1F30CA217027-01,,Investigating the role of miR-155 and the interferon response in FLT3-ITD+ AML,"WALLACE, JARED",UNIVERSITY OF UTAH,UT,"$40,644"
Pediatric Cancer,2017,NCI,1F31CA216976-01,,The Effect Of Cohesin Mutations In Hematologic Malignancies,"MCNULTY, MAUREEN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$38,129"
Pediatric Cancer,2017,NCI,5R01CA140729-07,,Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL),"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$454,699"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7124,NF-KB REGULATION OF A METABOLIC SHIFT IN CHILDHOOD SARCOMAS,"GUTTRIDGE, DENIS",OHIO STATE UNIVERSITY,OH,"$310,979"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7125,THE ROLE OF STAT3 SIGNALING IN CHILDHOOD SARCOMAS,"LIN, JIAYUH",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$335,087"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7126,INSULIN-LIKE GROWTH FACTOR SIGNALING AS A THERAPEUTIC TARGET IN CHILDHOOD SARCOMAS,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$278,191"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7127,ADMINISTRATIVE AND BIOSTATISTICS CORE,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$198,502"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7128,XENOGRAFT AND CELL LINE CORE,"HOUGHTON, PETER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$252,109"
Pediatric Cancer,2017,NCI,5P01CA165995-05,7129,COMPARTIVE ANIMAL CORE,"LONDON, CHERYL",OHIO STATE UNIVERSITY,OH,"$249,555"
Pediatric Cancer,2017,NCI,5R00CA178189-05,,Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma,"ZHU, SHIZHEN",MAYO CLINIC ROCHESTER,MN,"$249,000"
Pediatric Cancer,2017,NIAMS,5R01AR054447-10,,The Osteoblast as a Determinant of Leukemogenesis,"KOUSTENI, STAVROULA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$341,711"
Pediatric Cancer,2017,NCI,5R01CA180279-04,,Three-dimensional Model of Human Ewing Sarcoma,"MIKOS, ANTONIOS",RICE UNIVERSITY,TX,"$322,736"
Pediatric Cancer,2017,NCI,5R01CA178908-04,,Integrated models for metastatic phenotype and outcome prediction in osteosarcoma,"SPENTZOS, DIMITRIOS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$356,641"
Pediatric Cancer,2017,NCI,5F30CA210465-02,,Identification of chemosensitizing agents that block DNA repair by the Fanconi Anemia/Bloom Dissolvasome complex,"VOTER, ANDREW",UNIVERSITY OF WISCONSIN-MADISON,WI,"$34,423"
Pediatric Cancer,2017,NCI,5R01CA138744-08,,Tyrosine kinase inhibitors for the treatment of childhood AML,"BAKER, SHARYN",OHIO STATE UNIVERSITY,OH,"$343,388"
Pediatric Cancer,2017,NCI,5R01CA195732-02,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$348,844"
Pediatric Cancer,2017,NCI,1R01CA217092-01,,Mechanisms of Formation and Progression of Preleukemic Stem Cells,"STEIDL, ULRICH","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$397,371"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5328,Core A - Administrative Core,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$170,439"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5329,"Project 1 - In Utero Chemical Exposures, Immune Status, and Childhood Leukemia","METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$184,021"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5330,Project 2 - Identifying In Utero Exposures that are Risk Factors for Childhood Leukemia,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$176,369"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5331,"Project 3 - Prenatal Exposures, Constitutive Genetics, DNA Methylation & Childhood Leukemia","WIEMELS, JOSEPH",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$168,610"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5332,Core B - Community Outreach and Translation Core,"MILLER, MARK",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$87,541"
Pediatric Cancer,2017,NIEHS,5P50ES018172-08,5333,Core C - Mouse Model Service Core,"KOGAN, SCOTT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$63,020"
Pediatric Cancer,2017,NINR,5R21NR016580-02,,Barriers to Hospice and Palliative Care Utilization Among Adolescent and Young Adult Cancer Patients Living in Poverty,"MACK, JENNIFER",DANA-FARBER CANCER INST,MA,"$208,643"
Pediatric Cancer,2017,NCI,5F31CA192885-03,,The Role of DDX41 in the Spliceosome and Myeloid Neoplasia,"HIZNAY, JAMES",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$38,328"
Pediatric Cancer,2017,NCI,1F31CA217140-01,,Novel mechanisms and therapeutic strategies of refractory leukemia,"MELGAR, KATELYN",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$36,724"
Pediatric Cancer,2017,NCI,5F32CA203049-02,,Targeting PRL2 phosphatase in acute myeloid leukemia,"NABINGER, SARAH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$64,245"
Pediatric Cancer,2017,NCI,5K08CA184418-04,,PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia,"TASIAN, SARAH",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$169,657"
Pediatric Cancer,2017,NCI,5P50CA097257-15,7009,BRAIN TUMOR SPORT GRANT,"WIENCKE, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$190,971"
Pediatric Cancer,2017,NCI,5P50CA097257-15,7011,NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES,"JAMES, CHARLES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$272,244"
Pediatric Cancer,2017,NCI,5R01CA214146-02,,DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA,"GUTMANN, DAVID",WASHINGTON UNIVERSITY,MO,"$348,844"
Pediatric Cancer,2017,NCI,5R01CA194189-03,,Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations,"WIEMELS, JOSEPH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$963,827"
Pediatric Cancer,2017,NCI,5P50CA190991-04,5453,Administrative Core,"SAMPSON, JOHN",DUKE UNIVERSITY,NC,"$231,515"
Pediatric Cancer,2017,NINDS,5R01NS095411-03,,Targeting Tumors with NF1 Loss,"SANCHEZ, YOLANDA",DARTMOUTH COLLEGE,NH,"$544,581"
Pediatric Cancer,2017,NCI,1R01CA211657-01A1,,Role of long non-coding RNAs in sarcoma pathogenesis,"SWEET-CORDERO, ERIC","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$416,546"
Pediatric Cancer,2017,NCI,5T32CA136432-09,,Research Training in Pediatric Oncology,"ARMSTRONG, SCOTT",DANA-FARBER CANCER INST,MA,"$538,819"
Pediatric Cancer,2017,NCI,5R01CA187202-04,,Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor,"KAHALLEY, LISA",BAYLOR COLLEGE OF MEDICINE,TX,"$577,030"
Pediatric Cancer,2017,NCI,5U54CA210190-02,5200,Core 2: Cell and Whole Animal Genome Engineering,"LARGAESPADA, DAVID",UNIVERSITY OF MINNESOTA,MN,"$62,538"
Pediatric Cancer,2017,NCI,5U54CA210190-02,5201,Project 1: Physical modeling and dynamics of tumor cell migration mechanics,"ODDE, DAVID",UNIVERSITY OF MINNESOTA,MN,"$551,240"
Pediatric Cancer,2017,NINDS,5R01NS091620-03,,Precision Medicine For Pediatric Low-Grade Gliomas,"HAAS-KOGAN, DAPHNE",DANA-FARBER CANCER INST,MA,"$520,168"
Pediatric Cancer,2017,NCI,5R35CA197743-03,,Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment,"JAIN, RAKESH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,044,000"
Pediatric Cancer,2017,NCI,5R21CA209304-02,,Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases,"GREENFIELD, EDWARD",CASE WESTERN RESERVE UNIVERSITY,OH,"$206,843"
Pediatric Cancer,2017,NCI,1R21CA217137-01,,(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa,"EL-MALLAWANY, NADER",BAYLOR COLLEGE OF MEDICINE,TX,"$209,093"
Pediatric Cancer,2017,NCI,5R01CA181024-04,,Prevention of bone loss after pediatric hematopoietic cell transplantation,"SARAFOGLOU, KYRIAKIE",UNIVERSITY OF MINNESOTA,MN,$1
Pediatric Cancer,2017,NCI,5P01CA171983-05,7611,Targeting Ceramide Metabolism in AML,"KESTER, MARK",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$300,315"
Pediatric Cancer,2017,NCI,5P01CA171983-05,7612,Targeting Acid Ceramidase in AML,"LOUGHRAN, THOMAS",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$319,896"
Pediatric Cancer,2017,NCI,5P01CA171983-05,7613,Targeting Sphingosine Kinase in AML,"WANG, HONG-GANG",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$224,096"
Pediatric Cancer,2017,NCI,5P01CA171983-05,7616,Targeted Sphing''omics'' Core,"FOX, TODD",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$136,170"
Pediatric Cancer,2017,NCI,5P01CA171983-05,7411,Animal Modeling and Clinical Resources Core,"CLAXTON, DAVID",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$340,284"
Pediatric Cancer,2017,NCI,5UG1CA189812-04,,Essentia Health Community Cancer Research Program NCORP,"FRIDAY, BRET",ESSENTIA INSTITUTE OF RURAL HEALTH,MN,"$586,491"
Pediatric Cancer,2017,NCI,5UG1CA189816-04,,Iowa-Wide Oncology Research Coalition (I-WORC),"BEHRENS, ROBERT",IOWA ONCOLOGY RESEARCH ASSOCIATION,IA,"$1,030,000"
Pediatric Cancer,2017,NHLBI,5R01HL130937-02,,Genetic characterization of osteoblast-induced leukemias,"KOUSTENI, STAVROULA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$461,485"
Pediatric Cancer,2017,NINR,5F31NR015393-03,,Parents' Experiences in Pediatric Oncology Phase 1 Clinical Trials,"CRANE, STACEY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$4,468"
Pediatric Cancer,2017,NCI,5R01CA204396-02,,Aberrant signaling in acute myeloid leukemia,"KENTSIS, ALEX",SLOAN-KETTERING INST CAN RESEARCH,NY,"$459,674"
Pediatric Cancer,2017,NIBIB,5R21EB022309-02,,Motion-Robust Methods for Rapid Pediatric MRI without Sedation,"MEYER, CRAIG",UNIVERSITY OF VIRGINIA,VA,"$227,624"
Pediatric Cancer,2017,NCI,5K22CA197074-02,,Exosomic microRNAs and drug resistance in AML tumor microenvironment,"CHALLAGUNDLA, KISHORE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,958"
Pediatric Cancer,2017,NCI,5R01CA192662-03,,Methylation and mutations in RB1 and variants of synthetic folic acid metabolism,"ORJUELA, MANUELA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,$1
Pediatric Cancer,2017,NCI,5R35CA197697-03,,Mechanisms of regulation by RNA in acute myeloid leukemia,"TENEN, DANIEL",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$885,280"
Pediatric Cancer,2017,NCI,5R01CA202025-02,,Mapping cancer micro-environments for acute leukemia,"AIFANTIS, IANNIS",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$462,880"
Pediatric Cancer,2017,NIGMS,5SC1GM093999-08,,Molecular Analysis of RECQ1 Functions in Genome Maintenance,"SHARMA, SUDHA",HOWARD UNIVERSITY,DC,"$302,000"
Pediatric Cancer,2017,NINDS,5K02NS086917-05,,Functional Dissection of the K27M Histone Mutation in Vivo,"BECHER, OREN",LURIE CHILDREN'S HOSPITAL OF CHICAGO,IL,"$140,956"
Pediatric Cancer,2017,NCI,5R01CA143167-07,,DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome,"HILL, DANA",CHILDREN'S RESEARCH INSTITUTE,DC,"$407,577"
Pediatric Cancer,2017,NHLBI,5P01HL048546-22,8683,Preclinical evaluation of small molecules with proven benefit in FA animal models,"GROMPE, MARKUS",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$314,620"
Pediatric Cancer,2017,NCI,5R01CA180519-04,,Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions,"WANG, BINGHE",GEORGIA STATE UNIVERSITY,GA,"$442,311"
Pediatric Cancer,2017,NCI,5R01CA194473-03,,(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors,"GRAMATGES, MARIA",BAYLOR COLLEGE OF MEDICINE,TX,"$347,361"
Pediatric Cancer,2017,NCI,5R21CA208529-02,,(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach,"MODIANO, JAIME",UNIVERSITY OF MINNESOTA,MN,"$166,388"
Pediatric Cancer,2017,NINDS,5R01NS087213-03,,A novel STAT3-selective inhibitor for medulloblastoma therapy,"LIN, JIAYUH",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$339,684"
Pediatric Cancer,2017,NCI,5R01CA197137-03,,Early Phase Clinical Trials in Imaging and Image-Guided Interventions,"KIM, AERANG",CHILDREN'S RESEARCH INSTITUTE,DC,"$235,564"
Pediatric Cancer,2017,NCI,5R01CA136551-09,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$560,424"
Pediatric Cancer,2017,NCI,5R01CA194094-03,,Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML,"LI, HONG-YU",UNIV OF ARKANSAS FOR MED SCIS,AR,"$358,560"
Pediatric Cancer,2017,NCI,5U54CA196519-03,7037,Core B: Biospecimen/Pathology Core,"FOROUD, TATIANA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$123,510"
Pediatric Cancer,2017,NCI,5U54CA196519-03,7041,Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$419,407"
Pediatric Cancer,2017,NCI,5U54CA196519-03,7042,Project 4: Secondary Cancers Among NF1 Cancer Survivors,"NAKAMURA, JEAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$502,899"
Pediatric Cancer,2017,NCI,5R35CA210064-02,,Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer,"LOOK, A.",DANA-FARBER CANCER INST,MA,"$1,046,441"
Pediatric Cancer,2017,NCI,5P01CA078902-19,5394,Project 2: Stem Cell Allografts for Acute Leukemia and Myelodysplasia,"SANDMAIER, BRENDA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$239,833"
Pediatric Cancer,2017,NCI,5P01CA078902-19,7384,Program Integration and management,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$18,647"
Pediatric Cancer,2017,NCI,5R01CA157823-06,,Genetic Susceptibility and Biomarkers of Platinum-related Toxicities,"TRAVIS, LOIS",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$705,222"
Pediatric Cancer,2017,NCI,5R21CA198641-02,,New methods to address dilemmas in mixed recurrent-event and panel-count data,"ZHU, LIANG",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$176,284"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7962,Core 1: Administrative,"ALLIS, CHARLES",ROCKEFELLER UNIVERSITY,NY,"$119,788"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7963,Core 2: Genomics/Epigenomics Sequencing Core,"MAJEWSKI, JACEK",MCGILL UNIVERSITY,CANADA,"$349,222"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7964,Core 3: Quantitative Proteomics Core,"GARCIA, BENJAMIN",UNIVERSITY OF PENNSYLVANIA,PA,"$373,477"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7965,Project 1: Decoding Origin and Modeling Oncohistones in Pediatric Cancers,"JABADO, NADA",MCGILL UNIVERSITY HEALTH CTR RES INST,CANADA,"$282,942"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7966,Project 2:Elucidating Mechanisms of Chromatin Dysregulation by Oncohistones,"ALLIS, CHARLES",ROCKEFELLER UNIVERSITY,NY,"$387,793"
Pediatric Cancer,2017,NCI,5P01CA196539-03,7967,Project 3: Mechanisms of Methyltransferase Dysregulation by Oncohistones,"MUIR, TOM",PRINCETON UNIVERSITY,NJ,"$341,895"
Pediatric Cancer,2017,NIDDK,5R01DK100854-04,,Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells,"CHOU, STELLA",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$365,400"
Pediatric Cancer,2017,NIGMS,5P20GM103548-07,5159,Exploring the origins of childhood leukemia: investigating transcriptional networks in hematopoiesis and acute leukemia,"MILANOVICH, SAMUEL",SANFORD RESEARCH/USD,SD,"$299,267"
Pediatric Cancer,2017,NCI,5R01CA182526-04,,Targeting Neuroblastoma with armed T cells,"LUM, LAWRENCE",UNIVERSITY OF VIRGINIA,VA,"$765,563"
Pediatric Cancer,2017,NCI,5P30CA068485-22,7796,Cancer Health Outcomes and Control Research Program (CO) (Project-007),"FRIEDMAN, DEBRA",VANDERBILT UNIVERSITY,TN,"$87,030"
Pediatric Cancer,2017,NCI,5R01CA172723-05,,Predicting deficits in social competence for pediatric brain tumor survivors,"VANNATTA, KATHRYN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$551,277"
Pediatric Cancer,2017,NIDDK,5K08DK100661-04,,Mechanisms of gastric mucosal response to H. pylori infection at acidic pH,"MARCUS, ELIZABETH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$104,138"
Pediatric Cancer,2017,NHLBI,5F31HL131140-02,,The effects of LUC7L2 on alternative splicing in myelodysplastic syndromes,"HERSHBERGER, COURTNEY",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$34,430"
Pediatric Cancer,2017,NHLBI,5F31HL132420-02,,Aberrant Ubiquitin-Editing in the Pathogenesis of Myeloid Malignancies,"SMITH, MOLLY",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$37,025"
Pediatric Cancer,2017,NCI,5R01CA210165-42,,Targeting of Genes in the Mammalian Genome,"CAPECCHI, MARIO",UNIVERSITY OF UTAH,UT,"$468,711"
Pediatric Cancer,2017,NCI,5R01CA201788-02,,Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer,"POLLOCK, BRAD",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$208,949"
Pediatric Cancer,2017,RMAP,1DP2CA225433-01,,Targeted Advertising for Cancer Prevention,"LINOS, ELENI","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$2,377,500"
Pediatric Cancer,2017,NCI,2R42CA192656-02A1,,Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523,"DURDEN, DONALD","SIGNALRX PHARMACEUTICALS, INC.",CA,"$1,320,558"
Pediatric Cancer,2017,NIDCR,5DP5OD021403-03,,Cohesin gene mutations in tumorigenesis,"SOLOMON, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$1
Pediatric Cancer,2017,RMAP,5DP5OD021403-03,,Cohesin gene mutations in tumorigenesis,"SOLOMON, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$396,249"
Pediatric Cancer,2017,NCI,5K08CA212299-02,,Molecular Interactions of APOBEC3 Enzymes with the Cancer Genome,"GREEN, ABBY",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$148,742"
Pediatric Cancer,2017,NIDDK,5K08DK111234-02,,Identifying Barriers and Facilitators to the Implementation of Radiation-Free Imaging Protocols in the Emergency Department,"REPPLINGER, MICHAEL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$162,788"
Pediatric Cancer,2017,NCI,5R00CA178191-04,,Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia,"GURYANOVA, OLGA",UNIVERSITY OF FLORIDA,FL,"$252,971"
Pediatric Cancer,2017,NCI,5U01DK108334-03,,INSPPIRE to Study Pediatric Chronic Pancreatitis,"UC, ALIYE",UNIVERSITY OF IOWA,IA,"$190,000"
Pediatric Cancer,2017,NIDDK,5U01DK108334-03,,INSPPIRE to Study Pediatric Chronic Pancreatitis,"UC, ALIYE",UNIVERSITY OF IOWA,IA,"$230,104"
Pediatric Cancer,2017,NCI,5R25CA142519-07,,Enriching Communication Skills for Health Professionals in Oncofertility (ECHO),"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$230,954"
Pediatric Cancer,2017,NCI,5P01CA066996-19,7123,Mitochondrial determination of response to targeted AML therapies,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$368,794"
Pediatric Cancer,2017,NCI,5P01CA066996-19,7124,Determination of the mechanism of lenalidomide activity in acute myeloid leukemia,"EBERT, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$327,867"
Pediatric Cancer,2017,NCI,5P01CA066996-19,7126,Novel Epigenetic Approaches in AML,"BRADNER, JAMES",DANA-FARBER CANCER INST,MA,"$471,092"
Pediatric Cancer,2017,NCI,5K22CA190674-03,,Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia,"BARTH, BRIAN",UNIVERSITY OF NEW HAMPSHIRE,NH,"$161,692"
Pediatric Cancer,2017,NCI,5R50CA211466-02,,BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES,"RETTIG, MICHAEL",WASHINGTON UNIVERSITY,MO,"$175,922"
Pediatric Cancer,2017,NCI,5R01CA207530-02,,The Role of LMO2 in the Pathogenesis of T-cell Leukemia,"DAVE, UTPAL",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$364,962"
Pediatric Cancer,2017,NCI,5R50CA211452-02,,Biologic and Preclinical Studies of Myeloid Malignancies,"WONG, JASMINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$146,069"
Pediatric Cancer,2017,NIBIB,5P41EB015909-17,5061,TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.,"VAN ZIJL, PETER",HUGO W. MOSER RES INST KENNEDY KRIEGER,MD,"$182,592"
Pediatric Cancer,2017,NCI,2P50CA126752-11,8616,Immunotherapy of B cell lymphoma with  NK-T cells,"METELITSA, LEONID",BAYLOR COLLEGE OF MEDICINE,TX,"$363,790"
Pediatric Cancer,2017,NCI,5F31CA213994-02,,"Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response","MOLINA, ERIC",RICE UNIVERSITY,TX,"$44,044"
Pediatric Cancer,2017,NCI,5R50CA211428-02,,Histone Modification and Transcription Elongation in Human Cancer,"SMITH, EDWIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$185,418"
Pediatric Cancer,2017,NCI,5R50CA211534-02,,Development of novel therapies for megakaryocytic malignancies,"WEN, QIANG",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$130,753"
Pediatric Cancer,2017,NCI,5K07CA211847-02,,Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer,"BONA, KIRA",DANA-FARBER CANCER INST,MA,"$133,475"
Pediatric Cancer,2017,NCI,5F99CA212487-02,,The role of Lin28/let 7 pathway in Wilms' tumor,"YERMALOVICH, ALENA",HARVARD UNIVERSITY,MA,"$31,994"
Pediatric Cancer,2017,NCI,5F99CA212489-02,,System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,"KIM , HUEN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$41,724"
Pediatric Cancer,2017,RMAP,5U24HD090744-02,,Characterizing pediatric genomes through an optimized sequencing approach,"LEVY, SHAWN",HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY,AL,"$4,737,578"
Pediatric Cancer,2017,RMAP,5U24HD090743-02,,Genome Sequencing in support of the Gabriella Miller Kids First Pediatric Research Program,"GABRIEL, STACEY","BROAD INSTITUTE, INC.",MA,"$4,737,577"
Pediatric Cancer,2017,NICHD,5U54HD090215-02,8542,Project 1: Optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.,"RENBARGER, JAMIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$259,745"
Pediatric Cancer,2017,NICHD,5U54HD090215-02,8543,Project 2: Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation,"PACZESNY, SOPHIE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$213,258"
Pediatric Cancer,2017,NINDS,5R01NS096899-02,,Regulation of Shh Signaling by Cellular Energetics,"CHIANG, CHIN",VANDERBILT UNIVERSITY,TN,"$396,037"
Pediatric Cancer,2017,NCI,1P50CA206963-01A1,5027,Targeting MLL/Menin in AML,"ARMSTRONG, SCOTT",DANA-FARBER CANCER INST,MA,"$332,646"
Pediatric Cancer,2017,NCI,1P50CA206963-01A1,5028,Targeting SYK Kinase in AML,"STEGMAIER, KIMBERLY",DANA-FARBER CANCER INST,MA,"$334,016"
Pediatric Cancer,2017,NCI,1P50CA206963-01A1,5030,DC AML Fusion Cell Vaccination with Immune checkpoint Blockade,"FREEMAN, GORDON",DANA-FARBER CANCER INST,MA,"$256,093"
Pediatric Cancer,2017,NCI,5F31CA206388-02,,Sensitizing Primary Bone Tumors to Radiation Therapy,"MAMO, TEWODROS",MAYO CLINIC ROCHESTER,MN,"$49,044"
Pediatric Cancer,2017,NIGMS,5R01GM120607-02,,Genomic profiling of pathological R-loop formation in human diseases.,"CHEDIN, FREDERIC",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$314,000"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5991,Targeting Evolving Therapy Resistance,"MOSSE, YAEL",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$328,133"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5992,Exploiting Therapeutic Vulnerabilities,"WEISS, WILLIAM","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,133"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5994,Targeting the Pro-tumorigenic Microenvironment,"DECLERCK, YVES",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$328,134"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5995,Enhancing the Potency and Durability  of Immunotherapies,"SEEGER, ROBERT",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$328,134"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5996,Administrative Core,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$328,134"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5997,Clinical Trials and Translation,"MATTHAY, KATHERINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,134"
Pediatric Cancer,2017,NCI,1P01CA217959-01,5998,Biostatics,"GROSHEN, SUSAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$328,134"
Pediatric Cancer,2017,NCI,5P50CA196516-02,6943,Core B: Biospecimen and Pathology Resources Core,"KAPUR, PAYAL",UT SOUTHWESTERN MEDICAL CENTER,TX,"$379,125"
Pediatric Cancer,2017,NCI,5P50CA196516-02,6951,Project 4: Prognostic Significance and Therapeutic Potential of DROSHA Mutations in Wilms Tumor,"AMATRUDA, JAMES",UT SOUTHWESTERN MEDICAL CENTER,TX,"$318,286"
Pediatric Cancer,2017,NCI,5P30CA014089-42,8290,Tumor Microenvironment Research Program (Project-003),"DECLERCK, YVES",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$61,950"
Pediatric Cancer,2017,NCI,5P30CA016520-41,7999,Clinical Protocol and Data Management (Core 012),"VOGL, DAN",UNIVERSITY OF PENNSYLVANIA,PA,"$889,880"
Pediatric Cancer,2017,NCI,5P30CA016520-41,8007,Hematologic Malignancies Research Program,"STADTMAUER, EDWARD",UNIVERSITY OF PENNSYLVANIA,PA,"$73,099"
Pediatric Cancer,2017,NCI,5P30CA016520-41,8009,Pediatric Oncology Research Program,"BRODEUR, GARRETT",UNIVERSITY OF PENNSYLVANIA,PA,"$70,898"
Pediatric Cancer,2017,NCI,5P30CA062203-20,8736,Clinical Protocol and Data Management (CPDM),"O'BRIEN, SUSAN",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$150,882"
Pediatric Cancer,2017,NCI,5P30CA016058-41,5094,Clinical Protocol and Data Management (Core 017),"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$479,956"
Pediatric Cancer,2017,NCI,2T32CA128583-11,,Research Training in Childhood Cancer,"SHANNON, KEVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$290,621"
Pediatric Cancer,2017,NCI,1U01CA217862-01,,Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies,"DRUKER, BRIAN",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$1,004,845"
Pediatric Cancer,2017,NCI,1R01CA217991-01,,FANCM in repair of stalled replication forks,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$395,738"
Pediatric Cancer,2017,NCI,1R01CA219013-01,,Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor,"KALAPURAKAL, JOHN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$632,028"
Pediatric Cancer,2017,NCI,1R01CA218398-01,,Optimizing health related quality of life measurement in adolescent and young adult oncology: A PROMISing solution,"SALSMAN, JOHN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$479,149"
Pediatric Cancer,2017,NCI,1R01CA219345-01,,Small-molecule MDM2 degraders,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN,MI,"$615,748"
Pediatric Cancer,2017,NCI,1R01CA219686-01,,Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma,"DYER, MICHAEL",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$410,606"
Pediatric Cancer,2017,NCI,5P50CA171963-05,8326,Molecular Determinants of Decitabine Response,"LEY, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$391,498"
Pediatric Cancer,2017,NCI,5P50CA171963-05,8328,RNA Splicing Modulators for MDS/AML,"GRAUBERT, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$427,150"
Pediatric Cancer,2017,NCI,1R01CA219943-01,,Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas,"BEROUKHIM, RAMEEN","BROAD INSTITUTE, INC.",MA,"$502,615"
Pediatric Cancer,2017,NCI,1K99CA218832-01,,The role of histone demethylases in acute myeloid leukemia cell persistence,"VAN GALEN, PETER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$180,360"
Pediatric Cancer,2017,NCI,1K08CA218460-01,,Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas,"MURGA-ZAMALLOA, CARLOS",UNIVERSITY OF MICHIGAN,MI,"$106,531"
Pediatric Cancer,2017,NHLBI,1K23HL138291-01,,Investigating the role of the JAK/STAT3 Pathway in Clonal Proliferation and Immune Dysfunction in Myelodysplastic Syndrome,"FERRELL, PAUL",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$163,944"
Pediatric Cancer,2017,NCI,1K22CA218467-01,,Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis,"ADORO, STANLEY",CASE WESTERN RESERVE UNIVERSITY,OH,"$192,575"
Pediatric Cancer,2017,NINDS,1K08NS102532-01,,Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma,"GREEN, ADAM",UNIVERSITY OF COLORADO DENVER,CO,"$193,320"
Pediatric Cancer,2017,NCI,1R21CA220061-01,,Targeting EWS-ATF1 in CCSST,"XIAO, XIANGSHU",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$200,970"
Pediatric Cancer,2017,NIEHS,1R21ES028384-01,,Arylamine DNA adduct recognition in eukaryotic nucleotide excision repair,"CHO, BONGSUP",UNIVERSITY OF RHODE ISLAND,RI,"$209,154"
Pediatric Cancer,2017,NCI,1R21CA218625-01,,Memantine for Prevention of Cognitive Late Effects in Pediatric Patients  Receiving Cranial Radiation Therapy for Low Grade Glioma,"CONKLIN, HEATHER",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$156,165"
Pediatric Cancer,2017,NIDCR,1R03DE027121-01,,Expanded analysis of whole genome sequence data in cleft case-parent trios,"BEATY, TERRI",JOHNS HOPKINS UNIVERSITY,MD,"$163,500"
Pediatric Cancer,2017,NCI,1R21CA219352-01,,Role of m6A mRNA methylation in Neuroblastoma,"GREGORY, RICHARD",BOSTON CHILDREN'S HOSPITAL,MA,"$246,472"
Pediatric Cancer,2017,NINDS,1R21NS102776-01,,Tumor-initiating and propagating cells in MYC-driven medulloblastoma,"PEI, YANXIN",CHILDREN'S RESEARCH INSTITUTE,DC,"$218,750"
Pediatric Cancer,2017,NCI,1R21CA218790-01,,Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis,"HUANG, ALEX",CASE WESTERN RESERVE UNIVERSITY,OH,"$208,637"
Pediatric Cancer,2017,NINDS,1R21NS099417-01A1,,Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics,"KISSIL, JOSEPH",SCRIPPS FLORIDA,FL,"$477,230"
Pediatric Cancer,2017,RMAP,1U2CHL138346-01,7273,Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center,"RESNICK, ADAM",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$1,258,582"
Pediatric Cancer,2017,NCI,1R15CA219583-01,,Investigating roles for transcriptional co-activators Eya2 and Eya3 in normal development and rhabdomyosarcoma,"O'BRIEN, JENEAN",UNIVERSITY OF WISCONSIN-SUPERIOR,WI,"$335,740"
Pediatric Cancer,2017,NCI,1R15CA213199-01A1,,Discovery of New Differentiation Agents for Neuroblastoma Therapy,"DU, LIQIN",TEXAS STATE UNIVERSITY,TX,"$461,575"
Pediatric Cancer,2017,NINR,5F31NR016621-02,,Chronic Stress and Reproductive Function in Female Cancer Survivors,"HARDY, THERESA",MARQUETTE UNIVERSITY,WI,"$21,093"
Pediatric Cancer,2017,NCI,1R03CA212802-01A1,,The role of JMJD6 in MYC-mediated neuroblastoma,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$89,750"
Pediatric Cancer,2017,NCI,3P30CA021765-38S1,,Cancer Center Support Grant Year 35 (CCSG),"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$134,625"
Pediatric Cancer,2017,NCI,3P30CA021765-38S2,,Cancer Center Support Grant Year 35 (CCSG),"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$174,253"
Pediatric Cancer,2017,NCI,3R01CA076167-14S1,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",AUGUSTA UNIVERSITY,GA,"$24,361"
Pediatric Cancer,2017,NCI,1R03CA219724-01,,Identification of microRNA variants associated with acute lymphoblastic leukemia,"DEWAN, ANDREW",YALE UNIVERSITY,CT,"$83,750"
Pediatric Cancer,2017,NCI,1R03CA219725-01,,IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level,"PETROSIUTE, AGNE",CASE WESTERN RESERVE UNIVERSITY,OH,"$80,000"
Pediatric Cancer,2017,NCI,3P50CA171963-05S1,,Specialized Program Of Research Excellence (SPORE) in Leukemia,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$68,242"
Pediatric Cancer,2017,NCI,3R01CA175759-05S1,,Creating and Validating Child Adverse Event Reporting in Oncology Trials,"REEVE, BRYCE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$14,711"
Pediatric Cancer,2017,NCI,3U01CA176063-04S1,,ARID5B and disparities of childhood leukemia,"YANG, JUN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$99,290"
Pediatric Cancer,2017,NCI,1R21CA208618-01A1,,(PQ7) A multi-fluorescent intravital microscopy approach to study osteosarcoma,"INTINI, GIUSEPPE",HARVARD MEDICAL SCHOOL,MA,"$191,221"
Pediatric Cancer,2017,NCI,3R43CA203351-01S1,,The DEKK-TEC I-Corp Team,"MORGAN, LEE","DEKK-TEC, INC.",LA,"$50,000"
Pediatric Cancer,2017,NCI,1R01CA207109-01A1,,Role of the Histone Methyltransferase MLL4 in Medulloblastoma,"LEE, MIN GYU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$381,114"
Pediatric Cancer,2017,NINDS,3R01NS097271-01S1,,Deconstruct tumor microenvironment in medulloblastoma,"ZONG, HUI",UNIVERSITY OF VIRGINIA,VA,"$30,841"
Pediatric Cancer,2017,NCI,1R01CA207540-01A1,,"The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships across Time and around Periods of Distress","GAGE-BOUCHARD, ELIZABETH",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$722,488"
Pediatric Cancer,2017,NIGMS,2R01GM066233-13,,The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma,"WANG, JOANNE",UNIVERSITY OF WASHINGTON,WA,"$375,785"
Pediatric Cancer,2017,NCI,1R01CA204895-01A1,,Leukemia stem cell polarity and differentiation therapy,"MULLOY, JAMES",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$442,805"
Pediatric Cancer,2017,NCI,1R01CA212190-01A1,,"Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment","HARDY, KRISTINA",CHILDREN'S RESEARCH INSTITUTE,DC,"$471,490"
Pediatric Cancer,2017,NCI,1R01CA211734-01A1,,Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia,"LANGENAU, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$391,163"
Pediatric Cancer,2017,NCI,2R01CA090576-17,,STUDIES OF BCR-ABL LEUKEMOGENESIS IN MICE,"VAN ETTEN, RICHARD",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$293,550"
Pediatric Cancer,2017,NCI,1R01CA205239-01A1,,TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY,"FEHNIGER, TODD",WASHINGTON UNIVERSITY,MO,"$614,214"
Pediatric Cancer,2017,NCI,1R01CA213129-01A1,,Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment,"MITTELMAN, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$380,033"
Pediatric Cancer,2017,NCI,2R01CA166835-06,,Targeted Therapy for t(8;21)+ AML,"NIMER, STEPHEN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$345,375"
Pediatric Cancer,2017,NHLBI,2UG1HL069290-17,,ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML,"BRUNSTEIN, CLAUDIO",UNIVERSITY OF MINNESOTA,MN,"$151,167"
Pediatric Cancer,2017,NHLBI,1UG1HL138658-01,,Novel Strategies for Assessing and Optimizing Therapy for Minimal Residual Disease after Allogeneic Transplantation for AML and MDS,"MAZIARZ, RICHARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$202,916"
Pediatric Cancer,2017,NHLBI,2UG1HL069330-17,,University of Michigan Core Clinical Center for the BMT Research Network,"YANIK, GREGORY",UNIVERSITY OF MICHIGAN,MI,"$170,133"
Pediatric Cancer,2017,NIEHS,1R24ES028524-01,,Support for Infrastructure of Childhood Leukemia Environmental Research,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$391,983"
Pediatric Cancer,2017,NHLBI,2UG1HL069274-17,,Blood and Marrow Transplant Clinical Trials Network,"KURTZBERG, JOANNE",DUKE UNIVERSITY,NC,"$169,182"
Pediatric Cancer,2017,NHLBI,2UG1HL109526-07,,Reduction of Relapse Risk Through Incorporation of Novel Biologic Agents Following Reduced Intensity Haploidentical Donor Transplant for Acute Myeloid Leukemia.,"BASHEY, ASAD",NORTHSIDE HOSPITAL ATLANTA,GA,"$150,674"
Pediatric Cancer,2017,NCI,1K08CA212252-01A1,,Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia,"MURAKAMI, MARK",DANA-FARBER CANCER INST,MA,"$177,120"
Pediatric Cancer,2017,NINDS,1K08NS092891-01A1,,Uncovering Therapeutic Targets in Pediatric High Grade Gliomas with the H3K27M Mutation,"DANIELS, DAVID",MAYO CLINIC ROCHESTER,MN,"$182,141"
Pediatric Cancer,2017,NCI,1K07CA211955-01A1,,Building Resiliency Among Survivors of Cancers Diagnosed During Adolescence and Young Adulthood (AYAs): A Relaxation Response Resiliency Program for AYAs (3RP-AYA),"PEREZ-LOUGEE, GISELLE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$164,042"
Pediatric Cancer,2017,NCI,1K99CA212302-01A1,,Resistance To Targeted Immunotherapies:CART19 as a Paradigm,"RUELLA, MARCO",UNIVERSITY OF PENNSYLVANIA,PA,"$174,096"
Pediatric Cancer,2017,NCI,1K08CA194275-01A1,,Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia,"CHUNG, STEPHEN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$177,336"
Pediatric Cancer,2017,NCI,1K08CA207849-01A1,,The role of PLAG1 in Wilms tumor formation,"CHEN, KENNETH",UT SOUTHWESTERN MEDICAL CENTER,TX,"$157,185"
Pediatric Cancer,2017,NCI,1R01CA220467-01,,Cellular Basis for Radiation induced acceleration of sarcopenia in juvenile cancer survivors,"CHAKKALAKAL, JOE",UNIVERSITY OF ROCHESTER,NY,"$352,275"
Pediatric Cancer,2017,NCI,1R35CA210084-01A1,,Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies,"DIPERSIO, JOHN",WASHINGTON UNIVERSITY,MO,"$661,623"
Pediatric Cancer,2017,NCI,1R35CA220500-01,,Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes,"MARIS, JOHN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$683,163"
Pediatric Cancer,2017,NCI,1R35CA210104-01A1,,Epigenetic regulation of cellular plasticity and cancer cell fate,"SHI, YANG",BOSTON CHILDREN'S HOSPITAL,MA,"$753,725"
Pediatric Cancer,2017,NCI,1R35CA210065-01A1,,Molecular pathways and targeted therapies in human leukemia,"FERRANDO, ADOLFO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$849,333"
Pediatric Cancer,2017,NCI,1F31CA221002-01,,Engineering chimeric antigen receptors with VLR-mediated cancer recognition in CD5 edited gamma delta T cells,"FLEISCHER, LAUREN",EMORY UNIVERSITY,GA,"$44,044"
Pediatric Cancer,2017,NCI,1R13CA213937-01A1,,"State of the Science: Healthy Weight Maintenance During Pediatric, Adolescent, and Young Adult Cancer Treatment","LADAS, ELENA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$7,000"
Pediatric Cancer,2017,NCI,1R01CA216815-01A1,,Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity,"FERNANDEZ, CHRISTIAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$319,878"
Pediatric Cancer,2017,NCI,1F31CA213965-01A1,,Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma,"BAYLES, IAN",CASE WESTERN RESERVE UNIVERSITY,OH,"$44,044"
Pediatric Cancer,2017,NIA,1F30AG057213-01,,Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin,"ISKRA, BRIAN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$32,463"
Pediatric Cancer,2017,NCI,1F32CA221104-01,,The mRNA methylation program in leukemia,"PICKERING, BRIAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$59,166"
Pediatric Cancer,2017,NCI,1F30CA221345-01,,Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma,"DYSON, KYLE",UNIVERSITY OF FLORIDA,FL,"$38,084"
Pediatric Cancer,2017,NCI,1F30CA221109-01,,Epigenetic Regulation in High-Risk Leukemia,"PAYNE, JONATHON",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$47,425"
Pediatric Cancer,2017,NCI,1R01CA213062-01A1,,Molecular mechanisms of Nutrient sensing in cancer,"HAIGIS, MARCIA",HARVARD MEDICAL SCHOOL,MA,"$374,242"
Pediatric Cancer,2017,NCI,1R01CA221197-01,,White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy,"KAHALLEY, LISA",BAYLOR COLLEGE OF MEDICINE,TX,"$633,169"
Pediatric Cancer,2017,NCI,1R01CA213912-01A1,,Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia,"DOVAT, SINISA",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$353,876"
Pediatric Cancer,2017,NINDS,1F31NS100489-01A1,,Proliferation of cerebellar neural progenitors and Shh-driven medulloblastoma requires suppression of WNT by GSK-3,"OCASIO ADORNO, JENNIFER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$34,644"
Pediatric Cancer,2017,NCI,1R01CA215753-01A1,,Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma,"FABBRI, MULLER",CHILDREN'S HOSPITAL OF LOS ANGELES,CA,"$391,698"
Pediatric Cancer,2017,NINDS,1F31NS103500-01,,Molecular mechanisms mediated by ACVR1 G328V and H3K27M in diffuse intrinsic pontine glioma biology,"MENDEZ, FLOR",UNIVERSITY OF MICHIGAN,MI,"$35,460"
Pediatric Cancer,2017,NCI,1F31CA221157-01,,Mechanism of IL-10 protective effect in development of childhood B cell acute lymphoblastic leukemia,"FITCH, BRIANA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,749"
Pediatric Cancer,2017,NCI,1R01CA215405-01A1,,Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$657,845"
Pediatric Cancer,2017,NCI,1R01CA216981-01A1,,Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia,"FERRANDO, ADOLFO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$381,673"
Pediatric Cancer,2017,NCI,4R00CA188679-03,,Regulation of Apoptotic Priming and Competence in Healthy and Cancerous Cells,"SAROSIEK, KRISTOPHER",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$248,999"
Pediatric Cancer,2017,NCI,2R44CA203166-02,,Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II,"ZINNEN, SHAWN","MBC PHARMA, INC.",CO,"$1,138,475"
Pediatric Cancer,2017,NCI,7R01CA172385-05,,Validation and Development of WEE1 as a therapeutic target in AML,"PORTER, CHRISTOPHER",EMORY UNIVERSITY,GA,"$323,700"
Pediatric Cancer,2017,NCI,1R50CA211782-01A1,,COMPREHENSIVE INFORMATIC ANALYSES OF AML GENOMES AND EPIGENOMES,"MILLER, CHRISTOPHER",WASHINGTON UNIVERSITY,MO,"$107,259"
Pediatric Cancer,2017,NCI,1R50CA221848-01,,Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells,"BARTOM, ELIZABETH",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$173,980"
Pediatric Cancer,2017,NCI,261200800001E-111-0-142,,OCG Data Coordinating Center,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$525,000"
Pediatric Cancer,2017,NCI,1K08CA222630-01,,MUTANT AND WILD TYPE WT1 IN AML,"CHRISTOPHER, MATTHEW",WASHINGTON UNIVERSITY,MO,"$137,729"
Pediatric Cancer,2017,NCI,1K01CA222707-01,,Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis,"TRINH, BON",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$114,242"
Pediatric Cancer,2017,NINDS,1R21NS104596-01,,A Novel Non-Cell Autonomous Tumor Suppressor Function of H3K27me3 Demethylase UTX/Kdm6a in Medulloblastoma,"WU, JIANG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$202,500"
Pediatric Cancer,2017,NCI,1F99CA222742-01,,Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors,"WILLIAMS, ANNALYNN",UNIVERSITY OF ROCHESTER,NY,"$35,290"
Pediatric Cancer,2017,NCI,4R00CA175184-03,,A role for notch in self renewal in embryonal rhabdomyosarcoma,"IGNATIUS, MYRON",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$249,000"
Pediatric Cancer,2017,NCI,1U54CA224019-01,8421,"Genetics and Signaling of Drug Resistance and Sensitivity in AML Cell Lines, Xenografts, and Primary Patient Samples","AGARWAL, ANUPRIYA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$727,832"
Pediatric Cancer,2017,NCI,1U54CA224019-01,8422,Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML,"AGARWAL, ANUPRIYA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$727,832"
Pediatric Cancer,2017,NCI,1U01CA224166-01,,Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers,"CANTER, ROBERT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$1,639,796"
Pediatric Cancer,2017,NCI,1U01CA224182-01,,Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma,"DOW, STEVEN",COLORADO STATE UNIVERSITY,CO,"$1,672,078"
Pediatric Cancer,2017,NCI,1K07CA211956-01A1,,Improving Adverse Event Reporting on Cooperative Oncology Group Trials,"MILLER, TAMARA",EMORY UNIVERSITY,GA,"$169,044"
Pediatric Cancer,2017,NCI,2UM1CA154967-07,,Cancer Immunotherapy Trials Network Central Operations and Statistical Center,"CHEEVER, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$4,695,150"
Pediatric Cancer,2017,NCI,3R01CA196658-02S1,,A rapid spontaneous murine model of CN-AML,"GRIMES, H.",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$234,525"
Pediatric Cancer,2017,NCI,3P50CA171963-05S2,,Specialized Program Of Research Excellence (SPORE) in Leukemia,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$63,040"
Pediatric Cancer,2017,NCI,7U01CA199221-04,,Osteosarcoma: Patient Derived Xenograft Preclinical Testing,"GORLICK, RICHARD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$249,200"
Pediatric Cancer,2017,NCI,7R01CA201230-03,,The role of H3K79 methylation in IDH-mutant leukemia,"BERNT, KATHRIN",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$428,638"
Pediatric Cancer,2017,NCI,3R01CA204396-02S1,,Aberrant signaling in acute myeloid leukemia,"KENTSIS, ALEX",SLOAN-KETTERING INST CAN RESEARCH,NY,"$232,133"
Pediatric Cancer,2017,NCI,3R01CA204915-01A1S1,,Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics,"STEGMAIER, KIMBERLY",DANA-FARBER CANCER INST,MA,"$228,600"
Pediatric Cancer,2017,NCI,3R00CA181500-04S1,,The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development,"BLACKBURN, JESSICA",UNIVERSITY OF KENTUCKY,KY,"$233,050"
Pediatric Cancer,2017,NCI,1R43CA224723-01,,Biologic for the Treatment of High Risk B Cell Acute Lymphoblastic Leukemia,"MENG, XIANMEI","ELF ZONE, INC.",CA,"$299,999"
Pediatric Cancer,2017,NINDS,1F31NS101883-01A1,,Cooperation of BCL-xL and SHH in regulating cell survival during cerebellar neurogenesis and in medulloblastoma,"VELETA, KATHERINE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$34,774"
Pediatric Cancer,2017,NCATS,3UH2TR001373-01S1,,Wee1 and HDAC inhibition in relapsed/refractory AML,"GRANT, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$615,403"
Pediatric Cancer,2017,NCI,7R01CA164120-05,,Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia,"PARK, CHRISTOPHER",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$351,713"
Pediatric Cancer,2017,NIDCR,4R00DE023826-03,,Hedgehog Pathway Activity and Targeting in KCOT,"AMM, HOPE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$245,799"
Pediatric Cancer,2017,NCI,3U10CA180886-04S1,,COG NCTN Network Group Operations Center,"ADAMSON, PETER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$1,393,520"
Pediatric Cancer,2017,NCI,4R00CA197869-03,,Functional dissection of oncogenic enhancers,"HERRANZ BENITO, DANIEL",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$249,000"
Pediatric Cancer,2017,NCI,7K99CA204593-02,,Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer,"ALTMAN, BRIAN",WISTAR INSTITUTE,PA,"$86,521"
Pediatric Cancer,2017,NINDS,1R56NS102590-01,,Epigenetic and Kinase Pathway Interactions in Medulloblastoma,"AYAD, NAGI",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$383,750"
Pediatric Cancer,2017,NCI,3R01CA054498-25S1,,Late Effects of Treatment in Wilms Tumor Survivors and Offspring,"LEISENRING, WENDY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$44,259"
Pediatric Cancer,2017,NCI,4R00CA197498-04,,Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia,"CHEN, CHUN-WEI",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$249,000"
Pediatric Cancer,2017,NCI,4R00CA188595-03,,Determining the role of DNMT-interacting RNAs in myeloid disorders,"DI RUSCIO, ANNALISA",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$249,000"
Pediatric Cancer,2017,NCI,3UM1CA097452-15S1,,Pediatric Phase 1/Pilot Consortium,"WEIGEL, BRENDA",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$1,530,543"
Pediatric Cancer,2017,RMAP,3U24HD090743-02S1,,Genome Sequencing in support of the Gabriella Miller Kids First Pediatric Research Program,"GABRIEL, STACEY","BROAD INSTITUTE, INC.",MA,"$92,644"
Pediatric Cancer,2017,NCI,3U01HD052102-13S3,,Pediatric HIV/AIDS Cohort Study Data and Operations Center Substudy: Assessment of HPV associated anogenital morbidity in HPV-vaccinated perinatally HIV infected in Adolescent Medi Protocol of PHACS.,"SEAGE, GEORGE",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$238,387"
Pediatric Cancer,2017,NICHD,3U01HD052102-13S3,,Pediatric HIV/AIDS Cohort Study Data and Operations Center Substudy: Assessment of HPV associated anogenital morbidity in HPV-vaccinated perinatally HIV infected in Adolescent Medi Protocol of PHACS.,"SEAGE, GEORGE",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$188,545"
Pediatric Cancer,2017,NCI,7R03CA201953-03,,Adolescent Tanning and Social Media,"MORENO, MEGAN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$29,098"
Pediatric Cancer,2017,NIGMS,3P50GM115279-03S1,,Center for Precision Medicine in Leukemia (CPML),"RELLING, MARY",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$96,271"
Pediatric Cancer,2017,NCI,3R01CA215452-01S1,,Identifying and targeting oncogenic Myc enhancer control in pediatric tumors,"LIN, CHARLES",BAYLOR COLLEGE OF MEDICINE,TX,"$14,309"
Pediatric Cancer,2017,NIA,1ZIAAG000661-15,,Characterization of a Complex Involved In Rothmund-Thomson Syndrome,"WANG, WEIDONG",NIH,,"$528,991"
Pediatric Cancer,2017,NCI,1ZIACP004410-41,,Family Studies,"TUCKER, MARGARET",NIH,,"$2,450,222"
Pediatric Cancer,2017,NCI,1ZIACP010122-22,,Occupational Exposure Assessment,"FRIESEN, MELISSA",NIH,,"$469,306"
Pediatric Cancer,2017,NCI,1ZIACP010123-22,,Occupational and Environmental Determinants of Cancer among Women and Minorities,"BEANE FREEMAN, LAURA",NIH,,"$352,884"
Pediatric Cancer,2017,NCI,1ZIACP010125-22,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,463,246"
Pediatric Cancer,2017,NCI,1ZIACP010131-22,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON DE GONZALEZ, AMY",NIH,,"$4,206,471"
Pediatric Cancer,2017,NCI,1ZIACP010132-22,,Studies of Populations Exposed to Environmental Sources of Radiation,"BRENNER, ALINA",NIH,,"$816,497"
Pediatric Cancer,2017,NCI,1ZIACP010142-19,,Genetic Modifiers of Cancer Risk,"SAVAGE, SHARON",NIH,,"$445,441"
Pediatric Cancer,2017,NCI,1ZIACP010144-19,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"PEMOV, ALEXANDER",NIH,,"$9,903,769"
Pediatric Cancer,2017,NCI,1ZIACP010167-17,,General Studies of Epidemiology,"HOOVER, ROBERT",NIH,,"$199,659"
Pediatric Cancer,2017,NCI,1ZIACP010176-17,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$1,010,365"
Pediatric Cancer,2017,NCI,1ZIACP010219-07,,Studies of other risk factors for radiosensitive tumors,"KITAHARA, CARI",NIH,,"$358,696"
Pediatric Cancer,2017,NCI,1ZIACP010222-07,,Studies of Populations Exposed to Diagnostic Medical Radiation,"BERRINGTON DE GONZALEZ, AMY",NIH,,"$1,073,674"
Pediatric Cancer,2017,NIDCD,1ZIADC000064-17,,Clinical Analysis Of Disorders Of Hearing And Balance,"BREWER, CARMEN",NIH,,"$1,091,348"
Pediatric Cancer,2017,NICHD,1ZIAHD001803-24,,Genes and signals controlling mammalian hematopoiesis.,"LOVE, PAUL",NIH,,"$1,984,290"
Pediatric Cancer,2017,NCI,3U2CHL138346-01S2,,U2C Kids First Admin Supplement - cloud-based data storage and compute,"RESNICK, ADAM",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$1,800,000"
Pediatric Cancer,2017,NCATS,1ZIATR000044-03,,The development of multikinase inhibitors for the treatment of selected cancers,"THOMAS, CRAIG",NIH,,"$201,563"
Pediatric Cancer,2017,NHLBI,1ZIAHL002315-35,,Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments,"YOUNG, NEAL",NIH,,"$3,874,525"
Pediatric Cancer,2017,NCATS,1ZIATR000059-03,,Drug Repurposing in Pediatric Oncology,"SIMEONOV, ANTON",NIH,,"$44,666"
Pediatric Cancer,2017,NCI,1ZIABC004517-41,,DNA Repair in Human Cancer-Prone Genetic Diseases,"KRAEMER, KENNETH",NIH,,"$1,475,023"
Pediatric Cancer,2017,NCI,1ZIABC005093-39,,Growth-Differentiation Factors in Organogenesis,"PERANTONI, ALAN",NIH,,"$1,042,630"
Pediatric Cancer,2017,NCI,1ZIABC010008-22,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$506,056"
Pediatric Cancer,2017,NCI,1ZIABC010283-20,,DNA repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,645,808"
Pediatric Cancer,2017,NCI,1ZIABC010390-18,,Role of Neurotrophins in the Development of the Mammalian Nervous System,"TESSAROLLO, LINO",NIH,,"$731,359"
Pediatric Cancer,2017,NCI,1ZIABC010391-18,,Role of Trk Receptors in the Development and Function of Non-neuronal Structures,"TESSAROLLO, LINO",NIH,,"$713,520"
Pediatric Cancer,2017,NCI,1ZIABC010566-14,,Tumor and Metastasis Biology,"HELMAN, LEE",NIH,,"$190,916"
Pediatric Cancer,2017,NCI,1ZIABC010580-14,,Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"WARREN, KATHERINE",NIH,,"$13,327"
Pediatric Cancer,2017,NCI,1ZIABC010701-12,,Human Monoclonal Antibodies Against Cancer,"DIMITROV, DIMITER",NIH,,"$920,549"
Pediatric Cancer,2017,NCI,1ZIABC010709-12,,Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,"WARREN, KATHERINE",NIH,,"$53,307"
Pediatric Cancer,2017,NCI,1ZIABC010759-12,,Functional Genomics of Sarcoma,"MELTZER, PAUL",NIH,,"$1,290,697"
Pediatric Cancer,2017,NCI,1ZIABC010788-11,,Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,"THIELE-GALETTO, CAROL",NIH,,"$926,748"
Pediatric Cancer,2017,NCI,1ZIABC010789-11,,Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,"THIELE-GALETTO, CAROL",NIH,,"$499,018"
Pediatric Cancer,2017,NCI,1ZIABC010801-11,,Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,"WIDEMANN, BRIGITTE",NIH,,"$1,001,699"
Pediatric Cancer,2017,NCI,1ZIABC010806-11,,Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,"KHAN, JAVED",NIH,,"$237,202"
Pediatric Cancer,2017,NCI,1ZIABC010870-10,,Hematopoietic Stem Cell Transplant for GATA2 Deficiency,"HICKSTEIN, DENNIS",NIH,,"$1,515,161"
Pediatric Cancer,2017,NCI,1ZIABC010871-10,,Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,"MERLINO, GLENN",NIH,,"$38,444"
Pediatric Cancer,2017,NCI,1ZIABC010891-10,,Development of new antibody-based cancer therapies,"HO, MITCHELL",NIH,,"$1,311,816"
Pediatric Cancer,2017,NCI,1ZIABC010959-10,,Relationship between DNA damage detection and signaling,"NUSSENZWEIG, ANDRE",NIH,,"$1,645,808"
Pediatric Cancer,2017,NCI,1ZIABC010998-10,,Identification of Novel Mutations In Pediatric Cancers,"KHAN, JAVED",NIH,,"$711,607"
Pediatric Cancer,2017,NCI,1ZIABC010999-10,,"Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma","KHAN, JAVED",NIH,,"$711,607"
Pediatric Cancer,2017,NCI,1ZIABC011002-10,,Bioinformatics: Systems Biology of Pediatric Cancers,"KHAN, JAVED",NIH,,"$474,405"
Pediatric Cancer,2017,NCI,1ZIABC011007-10,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$1,226,826"
Pediatric Cancer,2017,NCI,1ZIABC011070-10,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$914,053"
Pediatric Cancer,2017,NCI,1ZIABC011295-08,,ALL immunobiology and the bone marrow niche,"FRY, TERRY",NIH,,"$463,229"
Pediatric Cancer,2017,NCI,1ZIABC011298-08,,Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,"WARREN, KATHERINE",NIH,,"$66,634"
Pediatric Cancer,2017,NCI,1ZIABC011299-08,,Noninvasive Evaluation of Pediatric CNS Tumors,"WARREN, KATHERINE",NIH,,"$66,634"
Pediatric Cancer,2017,NCI,1ZIABC011328-08,,Characterization of the Osteosarcoma Genome,"MELTZER, PAUL",NIH,,"$1,376,743"
Pediatric Cancer,2017,NCI,1ZIABC011332-08,,Tumor Microenvironment in Cancer Progression,"KAPLAN, ROSANDRA",NIH,,"$661,011"
Pediatric Cancer,2017,NCI,1ZIABC011334-08,,Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,"KAPLAN, ROSANDRA",NIH,,"$661,011"
Pediatric Cancer,2017,NCI,1ZIABC011378-07,,Studies of amplification in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$304,730"
Pediatric Cancer,2017,NCI,1ZIABC011387-07,,Studies of gene fusions in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$761,828"
Pediatric Cancer,2017,NCI,1ZIABC011407-07,,Establishment of an International DIPG Registry,"WARREN, KATHERINE",NIH,,"$13,327"
Pediatric Cancer,2017,NCI,1ZIABC011423-06,,Epigenetic studies in rhabdomyosarcoma,"BARR, FREDERIC",NIH,,"$457,096"
Pediatric Cancer,2017,NCI,1ZIABC011447-06,,Early Clinical Trials for Children with CNS Tumors,"WARREN, KATHERINE",NIH,,"$399,808"
Pediatric Cancer,2017,NCI,1ZIABC011470-06,,Development of Natural Product Leads as Anticancer Therapeutics,"BEUTLER, JOHN",NIH,,"$435,393"
Pediatric Cancer,2017,NCI,1ZIABC011504-05,,Study the roles of p53 and p53 mutants in mesenchymal stem cells,"HUANG, JING",NIH,,"$643,215"
Pediatric Cancer,2017,NCI,1ZIABC011514-05,,Investigating Pediatric CNS tumor biology,"WARREN, KATHERINE",NIH,,"$159,923"
Pediatric Cancer,2017,NCI,1ZIABC011565-04,,Adoptive T cell Therapy for Pediatric Leukemia,"FRY, TERRY",NIH,,"$1,080,868"
Pediatric Cancer,2017,NCI,1ZIABC011643-03,,Rare Central Nervous System Cancers Initiative,"GILBERT, MARK",NIH,,"$378,413"
Pediatric Cancer,2017,NCI,1ZIABC011692-02,,COP Laboratory,"LEBLANC, AMY",NIH,,"$891,438"
Pediatric Cancer,2017,NCI,1ZIABC011704-02,,Discovery of genes required for expression or activity of fusion oncogenes,"CAPLEN, NATASHA",NIH,,"$1,346,156"
Pediatric Cancer,2017,NCI,1ZIABC011722-02,,Genomic characterization and development of therapies for Rhabdomyosarcoma,"SHERN, JOHN",NIH,,"$294,563"
Pediatric Cancer,2017,NCI,1ZIABC011734-02,,Genomic dissection of tumor heterogeneity and progression,"SHERN, JOHN",NIH,,"$294,563"
Pediatric Cancer,2017,NCI,1ZIABC011745-01,,Development of biologic based therapies for rhabdomyosarcoma,"HESKE, CHRISTINE",NIH,,"$22,741"
Pediatric Cancer,2017,NCI,1ZIABC011754-01,,"Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1","REILLY, KARLYNE",NIH,,"$644,656"
Pediatric Cancer,2017,NCI,1ZIABC011774-01,,Development and translation of novel therapies for pediatric sarcoma,"HESKE, CHRISTINE",NIH,,"$68,223"
Pediatric Cancer,2017,NCI,1ZIASC006891-29,,Clinical Studies in Pediatric Solid Tumors,"HELMAN, LEE",NIH,,"$630,023"
Pediatric Cancer,2017,NCI,1ZIASC006892-29,,Molecular Biology of Pediatric Tumors,"HELMAN, LEE",NIH,,"$1,088,222"
Pediatric Cancer,2017,NCI,1ZIASC010354-18,,Clinical Development of Novel Drugs for Children with Refractory Cancers,"WIDEMANN, BRIGITTE",NIH,,"$667,799"
Pediatric Cancer,2017,NCI,1ZIASC010366-17,,Identification of Genes for Predicting Prognosis in Pediatric Cancers,"KHAN, JAVED",NIH,,"$237,202"
Pediatric Cancer,2017,NCI,1ZIASC010378-17,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$529,479"
Pediatric Cancer,2017,NCI,1ZIASC010384-17,,Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"HICKSTEIN, DENNIS",NIH,,"$202,021"
Pediatric Cancer,2017,NCI,1ZICBC011079-10,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$2,164,058"
Pediatric Cancer,2017,NCI,1ZIDBC010990-10,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$6,937,175"
Pediatric Cancer,2017,NCI,1ZIDBC011517-05,,Pediatric Oncology Branch Behavioral Science Core,"GLOD, JOHN",NIH,,"$1,247,135"
Pediatric Cancer,2017,NCI,1ZIDBC011729-02,,Chronic graft-versus-host disease in children and young adults,"BUXBAUM, NATALIYA",NIH,,"$11,435"
Pediatric Cancer,2017,NCI,1ZIDBC011792-01,,Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,"PACK, SVETLANA",NIH,,"$582,570"
Pediatric Cancer,2017,NCI,1ZIEBC011516-05,,Pediatric Oncology Branch Clinical Care and Education,"GLOD, JOHN",NIH,,"$4,988,540"
Pediatric Cancer,2017,NCI,1ZIGBC010931-10,,Comparative Biomedical Scientist Training Program,"SIMPSON, ROBERT",NIH,,"$1,299,544"
Pediatric Cancer,2017,NHLBI,1ZIAHL006163-05,,"Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.","HOURIGAN, CHRISTOPHER",NIH,,"$1,756,455"
Pediatric Cancer,2017,RMAP,3U2CHL138346-01S1,,U2C Kids First Admin Supplement - data transfer,"RESNICK, ADAM",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$61,638"
Pediatric Cancer,2017,NCI,3P30CA023108-38S4,5364,Protocol Review and Monitoring (PRMS),"LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,$965
Pediatric Cancer,2017,NINDS,1ZIANS003051-10,,Central Nervous System Drug Delivery Techniques,"YOULE, RICHARD",NIH,,"$438,081"
Pediatric Cancer,2017,NINDS,1ZIANS003052-10,,Molecular Pathogenesis of Neoplasia,"YOULE, RICHARD",NIH,,"$1,022,497"
Pediatric Cancer,2017,NINDS,1ZIANS003053-10,,Neuro-oncology of Familial Neoplasia Syndromes,"YOULE, RICHARD",NIH,,"$646,313"
Pediatric Cancer,2017,NINDS,1ZIANS003132-06,,Neurooncology of Benign Central and Peripheral Nervous System Tumors,"HEISS, JOHN",NIH,,"$588,894"
Pediatric Cancer,2017,NIA,1R56AG052501-01A1,,Mutant p53 rejuvenates aged stem cells through modulating epigenetic regulators,"LIU, YAN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$255,000"
Pediatric Cancer,2017,NIAID,1ZIAAI000732-23,,"Clinical, Immunological and Genetic  Analyses of ALPS and Related Disordrs","RAO, VEMULKONDA",NIH,,"$79,140"
Pediatric Cancer,2017,NINDS,3U24HD090744-02S1,,Characterizing pediatric genomes through an optimized sequencing approach,"LEVY, SHAWN",HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY,AL,"$2,765,194"
Pediatric Cancer,2017,NCI,3R01CA100159-07S1,,Etiology of Translocations in Hematopoietic Cells,"RICHARDSON, CHRISTINE",UNIVERSITY OF NORTH CAROLINA CHARLOTTE,NC,"$247,644"
Pediatric Cancer,2017,NIAID,1ZIAAI001187-05,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$673,451"
Pediatric Cancer,2017,NCI,4R00CA190861-03,,Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies,"OTT, CHRISTOPHER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$249,000"
Pediatric Cancer,2017,NIMHD,3R01MD007801-04S1,,Reducing racial/ethnic inequities in childhood cancer survivorship,"MILAM, JOEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$53,114"
Pediatric Cancer,2017,NHLBI,1ZIAHL006106-07,,Immunobiology and immunotherapy of leukemia,"BARRETT, AUSTIN",NIH,,"$1,117,867"
Pediatric Cancer,2017,NCI,261201700023C-0-0-1,,Drug Delivery System to Save Hearing During Pediatric Chemotherapy Regimens.  POP 09/19/17 - 06/18/18.,"SHIMOJI, MIKA","OTOMAGNETICS, LLC",MD,"$299,999"
Pediatric Cancer,2017,NCI,261201700052C-0-0-1,,SBIR PHS-2017-1 Topic 369 : Pediatric Cancer Drug Delivery System Research and Development. POP 09/21/2017 to 6/20/2018.,"QUINN, MICHAEL","HS-DESIGN, INC.",NJ,"$289,443"
Pediatric Cancer,2017,NCI,261201500003I-0-26100041-1,,IGF::OT::IGF Human Tumor Atlas Pilot Program,"AGARWAL, RACHANA","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$15,241,462"
Pediatric Cancer,2017,NCI,261200800001E-111-0-158,,MS PEDIATRIC MOONSHOT CORE,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$203,102"
